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Hydrogen sulphide (H2S), present in abundance in the hippocampus and cerebellum of 
rat, bovine and human brains, has recently been implicated in the pathogenesis of 
Alzheimer’s disease (AD). Furthermore, physiological levels of H2S have been observed 
to selectively potentiate N-methyl-D-aspartate (NMDA) receptor-mediated processes 
indirectly through events such as cAMP accumulation, thereby enhancing hippocampal 
long term potentiation. Employing cultured murine primary cortical neurons with full 
expression of glutamate receptors and sodium hydrosulphide (NaHS) as a H2S donor, 
H2S is demonstrated to induce apoptotic-necrotic continuum in a dose- and time-
dependent manner via activation of calcium-dependent proteases, calpains and when co-
applied, furthermore aggravated glutamate-induced neuronal death. This is intriguing as 
Kimura and Kimura, 2004 demonstrated a neuroprotective effect offered by H2S when 
co-treated with doses of glutamate up to 1 mM. Application of specific glutamate 
receptor pharmacological inhibitors further revealed that H2S-activated neuronal death 
signaling cascade revolving around NMDA and kainate (KA) receptors. Microarray 
analysis of H2S-treated samples with respect to that of NMDA-treated samples at (5 h, 15 
h and 24 h) showed 6, 780 genes with significant regulation of ± 1.5 fold-change in at 
least one out of six conditions. Among them included genes related to apoptosis, 
endoplasmic reticulum stress, calcium homeostasis, cell survival and cycle, heat shock 
proteins and chaperones, ubiquitin proteasome system (UPS), ionic and water channels. 
Validation by various established methods (i) Real-time PCR, (ii) Western Blotting and 
(iii) 2-DIGE proteomics (iv) Acridine orange (AO) re-distribution on integrity of 
lysosomal membrane, demonstrated consistent transcriptional regulatory trend with the 
microarray data. Comparison between H2S- and NMDA-mediated neuronal deaths 
 vi 
revealed involvement of identical signaling cascades, though the former initiated at a 
later time-point (15 h) than the latter (5 h). It could be speculated that H2S mediation of 
neuronal death converged to NMDA receptor signaling pathway, and that the delay in 
signaling as compared to direct induction of NMDA receptor by NMDA could be due to 
2 possiblities: a) the presence of upstream signaling pathway stimulated by H2S prior to 
NMDA receptor activation which is yet to be elucidated, b) direct stimulation of NMDA 
receptor by H2S, which demonstrated low affinity, and required much more ligand-
receptor complexes to exceed the threshold for trigger of dowsteam signaling. 
Occurrence of lysosomal rupture was also seen in H2S-induced neuronal death with 
concomitant transcriptional increase in cathepsins, an indication of calpains-cathepsin 
phenomenon. Since low H2S levels, and high protein nitration caused by peroxynitrite 
had been observed in AD brains, a comparison of global gene profiles of UPS in NaHS-, 
nitric oxide- and lactacystin-treated neurons revealed a late transcriptional down-
regulation, indicating UPS dysfunction was a consequential outcome of H2S-induced 
neuronal apoptosis. On the basis of these findings, it is important to re-evaluate the role 
of H2S with strong emphasis on NMDA and KA receptor contribution under physio-
pathological conditions such as stroke, Down syndrome and AD where perturbed H2S 
synthesis had been observed , and that the specific mechanism by which H2S stimulated 































1.1 Hydrogen sulphide (H2S) 
 
1.1.1 Toxicological properties 
 
Hydrogen sulphide (H2S), a colourless gas with a characteristic rotten egg-like pungent 
odour, has been viewed potential environmental pollutant (reviewed in US 
Environmental Protection Agency, 2003). Its toxicological properties have been 
extensively studied, with the main mechanism of intoxication due to dysfunction of 
mitochondrial respiration through potent inhibition of mitochondrial cytochrome c, which 
is more deadly than cyanide (Reiffenstein et al., 1992). High level of H2S has also been 
demonstrated to impose inhibition on other key cellular enzymes such as monoamine 
oxidase (Warenycia et al., 1989) carbonic anhydrase (Nicholson et al., 1998). However, 
following the discovery of substantial levels of H2S in mammalian tissues, especially in 
the brain, coupled with regulation of multiple physiological processes by this gaseous 
molecule, H2S is proposed to be a potential mediator in mammals.  
 
1.1.2 Chemical properties 
Under physiological conditions, i.e. aqueous medium at pH 7.4, H2S exists as a weak 




 differ in two 
different studies. Zhao and Wang, 2002 reported that only one-third of H2S remains as a 




 (hydrosulfide ion). Sodium 
hydrosulfide (NaHS) has been widely adopted as a convenient, water-soluble H2S donor. 




 in solution, then HS
–
 associates with H
+
 to produce 
H2S. In physiological saline, approximately ~33% of the H2S exists as the undissociated 
form (H2S), and the remaining ~66% exists as HS
-
 at equilibrium with H2S of a molar 
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, thus substantial in vivo amount of S
2-
 is uncommon. 
 
In contrast, a more recent study reported that the pKa of H2S at 37 °C in physiological 
saline to be 6.76, which in turns translate to approximately 18.5 % H2S and 81.5 % HS
- 
at 
equilibrium according to the Henderson-Hasselbach equation (Dombkowski et al., 2004). 
 
1.1.3 Biological properties 
1.1.3.1 In vivo synthesis of H2S 
Like nitric oxide (NO) and carbon monoxide which are synthesized endogenously in 
mammalian tissues from L-arginine by NO synthase and from heme by heme oxygenase 
respectively, H2S is produced from the amino acids cysteine and homocysteine by key 
transsulfuration enzymes, cystathionine-γ-lyase (CSE) and cystathionine-β-synthetase 
(CBS), using pyridoxal-5’-phosphate (vitamin B6) as a co-factor (reviewed in Moore et 
al., 2003; Navarra et al., 2000).  
 
CBS, a tetrameric protein allosterically regulated by S-adenosylmethionine and tumour 
necrosis factor α (Prudova et al., 2006), converts homocysteine to cystathionine and 
hydrolyses cysteine to equimolar amounts of serine and H2S and is present in abundance 
in the brain particularly the hippocampus and Purkinjes cells (Robert et al., 2003). 
Activity of brain CBS, like that of NO synthase, is both calcium- and calmodulin-
dependent (Dominy and Stipanuk, 2004), implying that temporary control of neuronal 
H2S production can be sustained by influx of Ca
2+
 into neurons following depolarization. 
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Alternatively, activity of CBS in the brain is controlled by hormonal regulation such that 
glucagon or cyclic adenosine monophosphate (cAMP)-elevating agents induced 
expression whereas insulin does the opposite (Stipanuk, 2004). 
 
On the other hand, prominent CSE activity is detected in peripheral tissues especially 
kidney, liver and blood vessels, though large amounts of both enzymes are present in the 
several mammalian livers (Ishii et al., 2004). CSE converts cystathionine to cysteine 
yielding pyruvate, NH3 and H2S. Increased expression of CSE has been noted after 
exposure to lipopolysaccharide (LPS; Li et al., 2005) and in animal disease models of 
pancreatitis (Bhatia et al., 2005) and Type I diabetes mellitus (Yusuf et al., 2005). In 
contrast to NO and carbon monoxide, data relating to the precise role and mechanism of 
H2S formation is still lacking. 
 
1.1.3.2 Occurrence of H2S in mammalian body 
H2S is detectable in rat and mouse plasma, and most tissues at a concentration of about 
50 µM (Richardson et al., 2000). However, H2S is present in greatest abundance, three-
folds of normal tissue level and close to toxic levels, in the brain, liver and kidneys 
(Richardson et al., 2000).  
 
In the human, rat and bovine brain, CBS has been identified to account for the major 
source of H2S which is highly expressed in the hippocampus and cerebellum (Abe et al., 
1996). The high endogenous concentrations of H2S measured in human, rat and bovine 
 5 
brain (50-160 µM) have led to the suggestion that H2S may function as an endogenous 
neuromodulator (Abe and Kimura, 1996; Kimura, 2000a). 
 
This is intriguing as these values are in sharp contrast to the toxicological property of H2S 
through potent inhibitory effect on the mitochondrial cytochrome c oxidase (Peterson, 
1977). Attempts to resolve this controversy translate into two explanations: Firstly, the 
limitation of the common employed simple spectrophotometric assay (involving 
acidification of zinc acetate-treated cellular samples to contain any free H2S and 
observing a colour change in the presence of a dye) only allows the measurement of total 
H2S and not H2S per se (Li and Moore, 2008); Secondly, H2S is rapidly degraded by 
cellular enzymes, sequestered by physically binding to haemoglobin or chemically react 
with several reactive oxygen species such as hydrogen peroxide (Geng et al., 2004) and 
superoxide radical (Mitsuhashi et al., 2005). As such, to accurately measure the presence 
of H2S in biologically active tissues is met with great obstacle. 
 
1.1.3.3 Degradation of H2S 
The pathway by which H2S is degraded in the mammalian body remains to be elucidated, 
although several hypotheses have been put forward. One of the most promising proposed 
mechanisms is that H2S is rapidly oxidized in the mitochondria to thiosulfate, which is 
further processed into sulfite and sulfate with the latter accounting for the majority of the 
by-product, though this pathway requires further evidence for confirmation of resultant 
H2S elimination. Sequestration of H2S through its methylation occurs in the cytosol by 
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thiol S-methyltransferase and yields methanethiol and dimethylsulfide, which in turn can 
bind to methaemoglobin to form sulfhaemoglobin (Li and Moore, 2008). 
 
1.1.4 Physiological and patho-physiological functions 
H2S is a highly lipophilic molecule that can easily penetrate cell membranes, though 
current research interests lie in its interaction with the cellular surfaces receptors that will 
elicit an intracellular signaling responses. 
 
1.1.4.1 Central Nervous System (CNS) 
H2S is shown to induce pain such as headache (Sjaastad and Bakketeig, 2006) possibly 
through vascular smooth muscle changes (Li and Moore, 2008). Activation of primary 
afferent neurons by H2S results in multiple consequences such as neurogenic airway 
inflammation through vanilloid receptor-1 signaling (Trevisani et al., 2005), contraction 
of rat urinary bladder (Patacchini et al., 2004), and increase Cl
-
 secretions in the 
submucosa and mucosa preparations in human and guinea pig (Schicho et al., 2006). 
Parenteral and planar injection of H2S result in stark difference in visceral nociception in 
rat, with the former causing inhibition (Distrutti et al., 2006), and the latter evoking 
pronociceptive activity in the hindpaw through activation of T-type Ca
2+
 channels 
(Kawabata et al., 2007). 
 
Abnormal biosynthesis of H2S has been implicated in middle cerebral artery occlusion 
models of stroke (Qu et al., 2006), Down syndrome (Kamoun et al., 2003) and possibly 
Alzheimer’s disease (AD; Clarke et al., 1998; Morrison et al., 1996; Beyer et al., 2004).  
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H2S has been shown to protect mouse primary cortical neurons by acting as a free radical 
scavenger in the event of oxidative stress (Whiteman et al., 2004; Whiteman et al., 2005; 
Whiteman et al., 2006), and against glutamate-mediated oxidative stress through 
elevation of intracellular glutathione levels and opening of KATP and Cl
- 
channels 
(Kimura and Kimura, 2004). In sharp contrast, published laboratory data from our study 
demonstrated that H2S induced neuronal apoptosis through glutamate receptors and 
involved activation of calpains with lysosomal rupture (Cheung et al., 2007). 
 
1.1.4.2 Cardiovascular System 
H2S is recently discovered to be a potent vasodilator in both in vitro and in vivo models, 
whose activity is speculated to be imposed by the opening of vascular smooth muscle 
KATP channels, causing increase KATP-dependent current with consequential 
hyperpolarization. This is based on the ability of KATP channels inhibitors such as 
glibenclamide, to neutralize the vasodilation effect of H2S in aortic rings exposed to high 
K
+
 and patch clamp studies in isolated rat aortic (Zhao et al., 2001) and mesenteric (Tang 
et al., 2005) smooth muscle cells. In in vitro models, H2S is demonstrated to dilate blood 
vessels such as rat aorta and portal vein (Ali et al., 2006; Zhao et al.,2001), rat mesenteric 
(Cheng et al., 2004) and hepatic (Fiorucci et al., 2005) and rabbit corpus cavernosum 
(Srilatha et al., 2007). Animal models reflected short-lived but dose-dependent drop in 
blood pressure following intravenous injections of H2S (Ali et al., 2006; Zhao and Wang, 
2002), with all the above mentioned observations in favour of H2S vasodilation effect. 
Similarly, with the presence of smooth muscles, H2S is also shown to relax airway (Kubo 
et al., 2007a) and gastrointestinal (Teague et al., 2002) in vitro. 
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Furthermore, chronic treatment with H2S has been demonstrated to be vasculoprotective 
through changes in vascular structure and function, providing a long term 
cardioprotection. Spontaneously hypertensive rats treated with daily doses of NaHS 
showed reduced hypertrophy of the intramyocardial arterioles and ventricular fibrosis 
(Shi et al., 2007). Also, rats with spontaneously hypertension and artificially induced 
hypoxic pulmonary hypertension demonstrated reduced CSE expression in the lungs with 
reduced H2S in the plasma (Li and Moore, 2008). These observations suggested that H2S 
deficiency may mean a predisposition to vasoconstriction, and maybe hypertension. H2S 
also inhibits proliferation of human vascular smooth muscle cells in vitro through 
elevation of extracellular signal-regulated kinase (ERK) and cyclin-dependent kinase 
inhibitor p21
cip/WAK-1
 phosphorylation (Yang et al., 2004), with further exposure resulting 
in cellular apoptosis (Yang et al., 2006). 
 
H2S also has a role to play in the heart through its negative ionotropic action in vivo and 
in vitro, which renders protection of the heart against ischemia (Pan et al., 2006), 
Lipopolysaccharide (LPS) injection (Sivarajah et al., 2006) and coronary artery ligation 
(Zhu et al., 2007). The mechanism of this cardioprotection effect is hypothesized to be 
caused by the opening of the KATP channels, coupled with the activation of the cardiac 
ERK and/or Akt pathways (Hu et al., 2007) and maintenance of mitochondrial structure 






1.1.4.3 Endocrine System 
Exogenously administered H2S and overexpression of CSE in rat insulinoma cells  
(Yang et al., 2005) and mouse pancreatic islets (Kaneko et al., 2006) resulted in reduced 
glucose-induced insulin release from the cells. Furthermore, high expressions of CSE and 
CBS are found in the pancreas, and in the disease state of streptozotocin-induced diabetic 
rats CBS level is significantly elevated (Yusuf et al., 2005). Thus it can be inferred that 
exogenously applied and endogenously produced H2S can inhibit insulin secretion and 
under physiological conditions, basal levels of H2S may help to maintain insulin release. 
However, since glibenclamide (a KATP channel inhibitor drug commonly used to treat 
diabetes by acting on pancreatic islet cells) is able to counteract H2S effect as previously 
mentioned, this strongly suggests that abnormally high H2S production may have a role in 
Type I insulin-dependent diabetes. 
 
H2S may have a key role to play in regulation of the hypothalamus-pituitary axis response 
to stress through a H2S dose-dependent induced decrease of K
+
-activated release of 
corticicotropin-releasing hormone in rat hypothalamus (Dello Russo et al., 2000).  
 
1.1.4.4 Immune System 
Much controversy lies in the role H2S plays in the event of inflammatory response, with 
current research outcomes demonstrating a dual function of H2S, be it pro- or anti-
inflammation. Evidence that support both opposing roles is equally massive. For instance, 
H2S is believed to evoke a pro-inflammatory response based on its ability to a) induce 
myeloperoxidase activity which causes increase tissue damage (Li et al., 2005), b) 
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increase vascular perfusion through vasodilation (Li and Moore, 2008), c) elevate 
intracellular adhesion molecule-1 expression and enhance leucocyte attachment in jejunal 
blood vessels (Zhang et al., 2007), d) promote expression of pro-inflammatory cytokines 
and chemokines in human monocytes and NF-κB in a sepsis animal model (Zhi et al., 
2007). An apparent observation is the rising levels of H2S and CSE coupled with the 
latter increase activity in inflammation models e.g. pancreatitis, endotoxic, septic and 
haemorrhagic shock, and that the application of CSE inhibitor, PAG, is able to reverse 
the inflammatory response (Bhatia et al., 2005; Collin et al., 2005; Li et al., 2005; Mok et 
al., 2004).  
 
In contrast, substantial evidence also learn support to H2S being an anti-inflammatory 
molecule. For instance, a) H2S promotes ulcer healing in rat (Wallace et al., 2007), b) 
H2S inhibits LPS-mediated NF-κB upregulation in macrophages (Oh et al., 2006, and 
TNF-α and NO expressions in microglial cells (Hu et al., 2006), c) H2S-evoked 
mesalamine release reduces colitis-induced leucocyte infiltration and expression of 
several pro-inflammatory cytokines (Fiorucci et al., 2007). 
 
 
1.2 Glutamate receptors (GluRs) 
L-glutamate is the major excitatory neurotransmitter in the mammalian CNS which is 
involved in the stimulation of specific receptors resulting in regulation of basal excitatory 
synaptic transmission and numerous forms of synaptic plasticity such as long-term 
potentiation (LTP) and long-term depression, which are believed to underlie learning and 
memory. Glutamate receptors (GluR) are a superfamily of receptors that are activated 
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upon glutamate application and divided into two broad categories: ionotropic and 
metabotropic, with the former comprising of N-methyl-D-aspartate (NMDA), alpha-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate (KA) 
subtypes based on their intrinsic ligand-gated ion channel activity and the latter being G-
protein coupled receptors and are further subdivided. They are so named upon the 
respective agonists that specifically activate each subtype. Activities of these receptors 
are predominantly linked to CNS and each serves distinct function. 
 
1.2.1 Ionotropic GluRs 
1.2.1.1 N-Methyl-D-Aspartate (NMDA) receptors 
Chemical structure and biological functions of NMDA receptors are further elaborated 
below. 
 
1.2.1.2 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) receptors 
The AMPA receptors subfamily consists of four members: GluR1-4 (Hollmann and 
Heinemann, 1994). Various homo- or hetero-tetrameric assemblies derived from these 
four different subunits give rise to functional AMPA receptors (Rosenmund et al., 1998). 
AMPA receptors travel in and out of the post-synaptic membrane, thus allowing 
regulation of synaptic strength through dynamic changes in synaptic AMPA receptor 
count (Malinow and Malenka, 2002). AMPA receptors are involved in the generation of 




1.2.1.3 Kainate (KA) receptors 
 KA receptors are multimeric assemblies of GluR5-7 and KA1-2 subunits. GluR5-7 
subunits have an approximately 10-fold lower affinity for kainate than KA1-2 subunits.  
Physiological role in KA receptors in the CNS is still understated, but they are classically 
implicated in epileptogenesis where intraperitoneal injection of kainate has long been 
used as a model for temporal lobe seizures. KA receptor activation, as opposed to that of 
AMPA receptor, results in inhibition of EPSP or the excitatory post synaptic current in 
the hippocampus (Vignes et al., 1998), and inhibitory post synaptic current which 
inhibition can be abolished by application of KA receptor antagonist (Clarke et al., 1997). 
 
1.2.2 Metabotropic GluRs (mGluRs) 
Metabotropic glutamate receptors (mGluR), unlike ionotropic GluR, are G-protein 
coupled and subdivided into three categories which are further differentiated to 8 
subtypes: Group I – mGluR1 and 5, group II – mGluR2 and 3, group III – mGluR4, 6, 7, 
8. They are involved in the regulation of neuronal excitation and synaptic transmission 
(Ossowska et al., 2007). Furthermore, the presence of mGluRs in the in the basal ganglia 
indicates their involvement in the nigrostriatal dopamine system (Feeley Kearney and 
Albin, 2003). 
 
1.3 NMDA receptors: A major subfamily of the GluR super family 
Functional NMDA receptors require the assemblies of both NR1, and NR2 subunits, 
which comprise of any one of the four separate gene products (NR2A-D). The 
essentiality for the expression of both subunits arises from the formation of the glutamate 
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binding domain at the junction of NR1 and NR2 subunits. Full activation of the NMDA 
receptors is achieved by the binding of glutamate and, glycine, a co-agonist binding on a 
site on NR1 subunit. The binding site for polyamines on the NR2 subunit is responsible 
for the regulation of the activity of NMDA receptors.  
 
NMDA subtype of ionotropic GluRs is the principal mediator of glutamate trophic 
activity (Balazs et al., 1988a). NMDA receptors are permanently anchored on the plasma 
membrane. Activation of NMDA receptors is demonstrated to exert survival-death 
continuum effect with increasing concentrations of glutamate (elaborated below). It is 
suggested that this is a consequence of differential recruitment of diverse NMDA 
receptor subtypes stimulated by moderate and high doses of glutamate respectively 
(Hardingham et al., 2002). This is observed in cortical neurons where NMDA receptors 
that contained the NMDA receptors subunit 2A (NR2A) suppressed staurosporine-
induced apoptosis, whereas those that comprised of the NR2B subunit led to excitotoxic 
cell death (Hardingham et al. 2002). However, a recent study by Habas et al., 2006 
demonstrated neuroprotection offered by NR2B against phosphatidylinositol-3 kinase 
(PI3K) inhibitor LY294002. As such, the significance of the relative ratio of NR2A to 
NR2B and their individual functions remain to be elucidated and may prove to be vital to 
the cell fate at any one time. 
 
1.3.1 Physiological roles of NMDA receptor activation 
Basal or moderate activation of NMDA receptors offers neuroprotection which is first 
reported in cultured cerebellar granule neurons (CGN). Exogenously administered 
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NMDA inhibits death of CGN upon exposure to suboptimal KCl concentration media 
(Balazs et al., 1988b; Yan et al., 1994), and that pretreatment with NMDA further 
enhance protection against glutamate-mediated excitotoxic neuronal death (Marini et al., 
1998). 
 
Modest NMDA receptor activation also promotes neuronal survival in the forebrain 
neurons. Application of exogenously NMDA attenuates neuronal death induced by 
staurosporine (Hardingham et al., 2002) or ethanol (Takadera and Ohyashiki, 2004) in 
cortical neurons. On the other hand, addition of antagonists of NMDA receptors trigger 
apoptosis in cultured rat primary cortical neurons (Takadera et al., 1999), and aggravates 
death induced by serum withdrawal (Hetman et al., 2000) or by a DNA-damaging agent, 
cisplatin (Gozdz et al., 2003). Induction of apoptosis in hippocampal, thalamic and 
cortical neurons in vivo is also seen in rats of post natal day 7 and 8 upon blockade of 
NMDA receptors (Ikonomidou et al., 1999). These suggest that homeostatic activation of 
NMDA receptors is vital for neuronal survival and proliferation. 
  
1.3.2 Patho-physiological role of NMDA receptor activation: Excitotoxicity in neurons 
Induction of massive release of glutamate from injured neurons is frequently observed 
during ischemic insults such as cardiac arrest, stroke, and head and spinal cord injury. 
Excitototoxic death occurs as a result of excessive release of glutamate from damaged 
neurons into the extracellular space, resulting in the over-stimulation of GluR on the 
neighbouring cell surfaces and subsequently neuronal death. Over-stimulation of 
ionotropic subtypes of GluR triggers massive influx of extracellular Ca
2+
, which together 
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with release of Ca
2+
 intracellular stores from ruptured organelles e.g. lysosomes, into the 
cytosol results in activation of Ca
2+
-dependent proteases calpains and protein 
phosphatase, calcineurin. 
 
It has been demonstrated that in the event of excitotoxic neuronal death, all three 
subtypes of ionotropic glutamate receptors, NMDA, AMPA and kA receptors are actively 
involved, with the NMDA receptor playing a major role in the mediation of massive Ca
2+
 
influx upon over-stimulation since it displays the highest Ca
2+
 permeability. (Hara and 
Snyder, 2007). Excessive NMDA receptor activation induces calcium influx and calcium 
release from intracellular stores resulting in the activation of cytoplasmic proteases such 
as calcium-dependent cysteine proteases (calpains; Simpkins et al., 2003) which 
hydrolyze cytoskeletal and other cellular proteins (e.g. alpha-fodrin; Posner et al., 1995; 
Siman et al., 1989). NMDA receptor activation can also result in the destabilization of 
lysosomes and release of lysosomal proteases (cathepsins; Graber et al., 2004; Tenneti et 
al., 1998) resulting in cell death. Similarly, NMDA receptor activation also induces 
caspase-3 activation and apoptosis (Graber et al., 2004; Tenneti et al., 1998). Not 
surprisingly, over-stimulation of the NMDA receptor by glutamate is implicated in 
neurodegenerative disorders including AD (Doraiswamy, 2003; Hynd et al., 2004), 
dementia associated with Down syndrome (Scheuer et al., 1996)  and Huntington’s 
disease (Arundine et al., 2004). Similarly, calpain activation (reviewed in Zatz & 
Starling, 2005; Carragher, 2006) and lysosomal dysfunction (Nixon et al., 2000; Bahr and 
Bendiske, 2002) are consistently observed in neurodegenerative diseases. 
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1.4 Association between H2S and NMDA receptors in CNS 
H2S stimulates cAMP accumulation in primary rat cerebral, cerebellar neurons and glial 
cell lines, as opposed to the stimulatory actions of other common neurotransmitters such 
as NO that induce cyclic guanosine monophosphate(cGMP) production (Kimura et al., 
2000b). It has been further demonstrated that inhibition of adenyl cyclase prevents signal 
transduction through H2S-induced NMDA receptor stimulation in NMDA overexpressing 
Xenopus oocytes (Kimura et al., 2000a). This implies the existence of a H2S-activated 
signaling cascade revolving around NMDA receptors. Physiological levels of H2S have 
been observed to selectively potentiate NMDA receptor-mediated processes indirectly 
through events such as cAMP accumulation, thereby enhancing hippocampal LTP 
(Kimura et al., 2000a). Moreover, H2S production by CBS is increased by NMDA, 
AMPA and L-glutamate though it is tightly regulated by calcium-cadmodulin family. 
Furthermore, H2S is capable of inducing calcium waves in primary cultures of rat 
astrocytes and hippocampal slices through calcium channels activation, a phenomenon 
also observed in NMDA receptors over-stimulation (Nagai et al., 2004). 
 
1.5 Association between H2S and NMDA receptors in neurodegeneration 
Interestingly, perturbed synthesis of H2S has also been implicated in stroke (Qu et al., 
2006), Down syndrome (Kamoun et al., 2003) and possibly AD (Clarke et al., 1998; 
Morrison et al., 1996; Beyer et al., 2004). Brains of AD patients showed significantly 
lower H2S levels and substantially higher levels of brain protein nitration caused by 
peroxynitrite as compared to normal subjects, though no change in L-cysteine level or 
CBS was detected. This inverse correlation is unsurprising since thiols are well identified 
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to be effective inhibitors of peroxynitrite. NMDA receptor activation leads to intracellular 
tyrosine nitration by peroxynitrite. Decreased H2S levels could imply a higher turnover 
by binding to and potentiating glutamate-mediated transmission via NMDA receptors 
which could be responsible for the neuronal loss in AD. Alternatively, it could also 
reflect a high consumption of H2S by reactive oxygen species (ROS) existing in high 
concentration in AD. As a result, it is postulated that H2S may function as a potential 
endogenous neuromodulator. 
 
Nevertheless, the effects of H2S on neurons are poorly understood and under some 
conditions, such as oxidative stress, H2S may exert antioxidant properties. For example, 
H2S can scavenge NO (Whiteman et al., 2006), peroxynitrite (Whiteman et al., 2004) and 
the myeloperoxidase-derived oxidant hypochlorous acid (Whiteman et al., 2005). 
Consistent with this, Kimura and Kimura, 2004 recently showed that H2S protected 
mouse primary neurons against glutamate-mediated oxidative stress through increasing 
intracellular glutathione levels. It demonstrated that the addition of 100 µM NaHS to 
immature neurons did not exert any cytotoxicity and markedly prevented cell death 
induced by high concentrations of glutamate (1 mM; Kimura and Kimura, 2004).  
 
Intriguingly, our study demonstrated that H2S increased glutamate-induced cell death 
through NMDA receptor-dependent pathway, involving calpain rather than caspase 
activation in a glutamate receptor expressing mouse primary cortical neuronal model 
(Cheung et al., 2007). This H2S-induced apoptotic cell death also involved lysosomal 
rupture. It is suggested that immature neurons were used in the former study done by 
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Kimura and Kimura, 2004 and as such did not express any functional glutamate 
receptors.  
 
In summary, since H2S has been produced at high levels in the brain and its biological 
functions as an endogenous neuromodulator have been established, in addition to its 
implication in numerous incurable neurodegenerative disorders, it is of utmost 
importance to decipher its molecular signaling cascade to provide more in-depth 
understanding of its precise role in these disease pathogeneses, since at current moment 
neurodegeneration poses a severe problem in the elderly population  Furthermore, as 
controversy still exists over the outcomes of H2S administration on neuronal cell types in 
relation to GluRs, precise role of H2S in the brain deserves careful and extensive study, 



















1.7 Aims and Objectives 
• To ascertain mechanism of H2S-mediated neuronal death pertaining to NMDA 
receptor involvement. 
• To understand the global gene regulation profile during H2S-mediated neuronal 
death. 
• To establish the association between NMDA receptors and H2S-mediated 
neuronal death through global gene profiles comparison between NMDA and 
H2S-induced deaths 
• To compare Ubiquitin-Proteasome System (UPS) gene profile of H2S-induced 































2.1 Mouse Neocortical Neuronal Cell Culture Preparation 
• Foetal cortices of Swiss albino mice 
• Trypsin 
• Neurobasal (NB) medium (GIBCO) 
• B-27 supplement 




Neocortical neurons (gestational days 15 or 16) obtained from foetal cortices of Swiss 
albino mice were used to prepare the primary cultures employing previous described 
procedures with modifications (Cheung et al., 2000). Microdissected cortices were 
subjected to trypsin digestion and mechanical trituration. Cells were collected by 
centrifugation and resuspended in NB medium containing 2.5 % B-27 supplement, 1 % 
penicillin, 1 % streptomycin, 0.25 % GlutaMAX-1 supplement and 10% dialyzed FCS.  
24-well plates previously coated with poly-D-lysine (100 µg/ml) were seeded with cells 




 and used for subsequent experiments. The cultures were 
maintained in a humidified 5 % CO2 and 95 % air incubator at 37 °C. 
Immunocytochemical staining of the cultures at day 5 in vitro for microtubule-associated 
protein 2 and glia fibrillary acidic protein revealed > 95 % of the cells were neurons with 
minimal contamination by glia (Cheung et al., 1998).  All experiments involving animals 
were approved by the National University of Singapore, and were in accordance with the 
US Public Health Service guide for the card and use of laboratory animals.   
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2.2 NaHS Stock Preparation 
• NaHS (powdered form; stored in dessicator at r.t.) 
• Autoclaved Milli-Q water 
 
Anydrous form of NaHS was freshly prepared in water upon usage to get a stock 
concentration of 100 mM. Desired concentrations were achieved through dilution with 
NB medium. 
 
2.3 Cell Lysate Preparation using RIPA Buffer 
• RIPA buffer at -20 °C (10 mM Tris-HCl at pH 7.4, 1 % NP-40, 0.5 % sodium 
deoxycholate, 150 mM NaCl, 1 mM EDTA, 2 mM EGTA, 0.1 % SDS, 25 mM 
sodium fluoride, 2 mM sodium orthovanadate, 10 mM pyrophosphate, Protease 
inhibitor tablet (Roche 1873580) 
• Rubber policeman 
• Eppendorf tubes 
• 5 × SDS loading buffer at r.t. (0.5 M Tris-HCl at pH 6.8, 20 % glycerol, 10 % 
SDS, 0.01 % bromophenol blue, 20 % freshly added β-mercaptoethanol before 
use) 
• RC-DC Protein Assay (Protocol provided by Bio-Rad) 
• Spectrophotometer 
 
Cells were lysed with RIPA buffer (10 mM Tris HCl, pH 7.4, 1 mM EDTA, 150 mM 
NaCl, 1 % Nonidet-P40, 0.5 % deoxycholate, 0.1 % SDS) and spun down at 14,000 rpm 
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for 10 min to obtain the supernatants whose concentrations were quantitated using Biorad 
RC-DC assay. After which, the absorbance of each sample solution was read under 
visible light using the Lowry HS assay. 25 µl of 5 × SDS (with 20 % freshly added β-
mercaptoethanol) was added to each pellet sample. 
 
2.4 Western Blotting of RIPA-extracted samples 
• Pre-cast 12 % polyacrylamide gel  
12 % Resolving gel (1.7 ml MilliQ water, 2 ml 30% Polyacylamide/Bis, 1.25 ml 
Resolving gel buffer, 25 µl Fresh 10% APS, 5µl TEMED) 
4 % Stacking gel (1.525 ml MilliQ water, 325 µl 30% Acrylamide/Bis, 625 µl 
Stacking gel buffer, 12.5 µl Fresh 10% APS, 3.75 µl TEMED) 
• 5 × SDS loading buffer at r.t. (0.5 M Tris-HCl at pH 6.8, 20 % glycerol, 10 % 
SDS, 0.01 % bromophenol blue, 20 % freshly added β-mercaptoethanol before 
use) 
• 5 × electrophoresis buffer (NUMI) 
• MilliQ water 
• Precision Plus Marker 
• 10× transfer buffer at r.t (30.285 g Tris and 144.13 g Glycine / 1L MilliQ water) 
• Methanol 
• PVDF membrane 
• Filter papers 
• PowerPac 
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• 5 × TBS at pH 7.5 at r.t. (30.285 g Tris and 43.83 g /L MilliQ water; pH adjusted 
with 5 M hydrochloric acid) 
• Tween-20 
• Blocking buffer at 4 °C (4 % skimmed milk (Anlene), 1 % Bovine Serum 
Albumin (BSA) and 0.1 % Tween-20 in 1X TBS) 
• Mouse secondary antibody (Pierce 0031430) 
• Rabbit Secondary antibody (Bio-rad 170-6515) 
• West Femto (Pierce 34095) 
• Primary Antibodies used in Western Blotting 
a. Anti-Caspase-3 polyclonal antibody (Pharmingen) 
b. Anti-α-fodrin monoclonal antibody (Affinity Research Products (UK)) 
c. Anti-glutamate receptor 2 and 4 monoclonal antibody (BD Biosciences 
PharMingen)  
d. Anti-glutamate receptor (NMDAR1) monoclonal antibody (BD Biosciences 
PharMingen)  
e. Anti-Annexin A3 polyclonal antibody raised by Dr. Françoise Russo-Marie 
(Institut Cochin, Paris, France) 
f. Anti-HSP47 monoclonal antibody 
g. Anti-β-tubulin monoclonal antibody (Cytoskeleton Inc.) 
 
10 µg of proteins from individual supernatant samples containing 1 × SDS (with 20 % 
freshly added β-mercaptoethanol) and 5 µl of individual pellet samples were heated to 
100 °C for 5 min, and allowed to cooled at r.t.. The samples were subsequently 
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centrifuged for 2 min at r.t. at maximum speed. The samples were subjected to SDS-
PAGE (12 % gel) and immunoblotted using commercially available antibodies stated 
above. Anti-tubulin (1:1000; Cytoskeleton Inc.) monoclonal antibody was used for 
internal control purpose. Signals were detected using chemiluminescence (Pierce 
Biotechnology Inc., Rockford, IL, USA) and exposure to X-ray film (Eastman Kodak 
Company, Rochester, New York).  
 
2.5 MTT Reduction Assay 
• Cell culture plates 
• MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide] 
• RPMI medium 1640 (GIBCO) 
• DMSO (Merck) 
• 96-well Nunc plate 
• Tecan Plate Reader 
 
MTT assay was employed as indexes of cell survival. MTT [3-(4,5-dimethylthiazole-2-
yl)-2,5-diphenyltetrazolium bromide] was dissolved at a stock concentration of 5 mg/ml 
in RPMI medium 1640 (GIBCO). 30 µl MTT solution was added to each of the 24-well 
plate containing cells in 300 µl culture medium. The plate was incubated at 37 °C for 20 
min and the culture medium was removed by aspiration. The formazan formed in each 
well was dissolved by an aliquot of 200 µl DMSO and the absorbance of the solution was 
read using a TECAN plate reader at a wavelength of 570 nm. Result from MTT assay 
was presented as mean ± SE. 
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2.6 LDH release assay 
• LD-50 Kit (Sigma) 
 
Leakage of lactate dehydrogenase (LDH) into the culture medium was measured at 340 
nm using a commercially available kit (Sigma; LD-50) and data are expressed as a 
percentage of LDH activity from cells lysed with 0.1 % Triton X for 20 min at 37 °C. 
 
2.7 Lysosomal membrane stability assay 
• Acridine Orange 
• Neurobasal medium 
• Fluorescence microscope 
 
Lysosomal membrane integrity was evaluated by acridine orange (AO) uptake assay 
(Zdolsek et al., 1990). Cells were stained with acridine orange to a final concentration of 
5 µg/ml by freshly preparing a 200 µg/ml solution in Neurobasal medium (Yap et al., 
2006).  After incubation for 15 min at 37 ˚C, the stained cells were washed twice with 
PBS. AO is a fluorescent probe of the internal pH of the lysosomes as it can enter freely 
and accumulate in the acidic compartments of living cells. During exposure to blue light, 
AO-loaded cells show red granular fluorescence and green diffuse fluorescence. This 
property can be exploited to reveal impairments of the lysosomal proton gradient. Once 
rupture of lysosomes occurs, proteolytic enzyme (lysosomal proteinase) such as 
cathepsins are released from the ruptured lysosomes into the cytosol, relative intensities 
of red and green fluorescence were simultaneously examined microscopically using blue 
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light for excitation. Acridine orange relocation from lysosomes to cytosol, and the 
decrease of granular (lysosomal) red fluorescence in combination with the increased 
diffused (cytosolic) green fluorescence, was indicative of deterioration of lysosomal 
membrane stability. 
 
2.8 Total RNA Extraction and Isolation 
• RNeasy Mini Kit (50) (Qiagen Cat. No. 74104) 
• Filtered pipette tips 
• Pipetman 
• Eppendorf tubes 
 
RNA from samples was extracted using RNeasy Mini Kit according to the 
manufacturer’s instructions. All pipette tips used for RNase-free and filtered. The 
following procedures were suited for 1 million cultured cells per sample. 1.5 µl of the 
RNA sample was aliquot for spectrophotometric quantification and 1 µl for Bioanalyzer 
analysis. 
 
2.9 Determination of RNA Concentration 
• Distilled-treated water 
• Total RNA samples 
• Nanodrop ND-1000 Version 3.2.1 
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RNA concentration was determined by adding 1.5 µl of the RNA sample on the pedestal 
of the equipment. The pedestal was thoroughly cleaned with distilled water using 
laboratory wipe before usage and measurement was blanked with water. It was necessary 
to ensure that the RNA solution was mixed well. Absorbance reading was taking at 260 
nm and 280 nm. One unit of OD260nm was equivalent to 40 µg/ml RNA content. In this 
case, concentration of RNA was obtained by multiplying 40 to the absorbance reading at 
260 nm and then to 50 (dilution factor). Ratio of OD260nm:OD280nm would give the purity 
of the RNA sample. 
 
2.10 Checking of RNA Quality 
• RNA loading buffer (Sigma Cat. No. 1486) 
• RNA dilution buffer 
• Heat block 
• E-gene HDA-GT12 genetic analyzer 
 
1 µl of total RNA sample was mixed with 1 µl RNA loading buffer in 0.2 ml tube. The 
mixture is heated at 70ºC for 4 min on a heat block and then spun down to collect any 
condensation. The total volume of the mixture was topped up to 10 µl with the RNA 
Dilution buffer and mix by gently pipetting up and down a few times. Sample mixtures 
were analyzed immediately on the E-gene HDA-GT12 System. Two bands, both 18S and 




2.11 cDNA Synthesis/ Reverse transcription 
• Taqman reverse transcription reagents (Applied Biosystems) 
• DEPC-treated water 
• MicroAmp Optical Reaction tubes 
• Filtered pipette tips 
• Pipetman 
• Thermal cycler 
 
Reverse transcription was carried out according to steps specified by the manufacturer. In 
a 0.2 ml microcentrifuge tube, a reaction mix was prepared for total RNA to be reversed 
transcribed. The following volumes were recommended for each sample.  
Component Per Sample (ul) 
10X RT-buffer 1 
25 mM MgCl2 2.2 
deoxyNTPs Mixture 2 
Random Hexamers 0.5 
Rnase Inhibitor 0.2 
Reverse Transcriptase (50 U/µl) 0.625 
Total 6.525 
 
In labelled microcentrifuge tube (MicroAmp Reaction Tube), volume corresponding to 
200 µg of each RNA sample was added to the reaction mix corresponding to one sample 
(6.525 µl), and the volume of RNase-free water used was 3.475 – RNA sample volume in 
a 10-µl reaction (µl). The tube was capped and centrifuged to eliminate any bubbles and 













HOLD HOLD HOLD 
Temperature 25 °C 37 °C 95 °C 
Time 10 min 60 min 5 min 
Volume 10 µl 
 
A primer incubation step of 25 °C for 10 min is necessary to maximise primer-RNA 
template binding when using random hexamers for first strand cDNA synthesis. 37 °C for 
60 min in the reverse transcription step is necessary for reverse transcribing 18S only. 
After thermal cycling, all cDNA samples were stored at -15 to -25 °C. 
 
2.12 Real-time Polymerase Chain Reaction (Real-time PCR) 
• Taqman Probes (Applied Biosystems) 
• 18S Taqman Probe 
• Taqman Master Mix 
• DEPC-treated water 
• cDNA 
• 96-well optical reaction plates and adhesive cover 
• Eppendorf tubes 
• Pipetmans 
• Filtered Pipette tips 
• Benchtop microcentrifuge 
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Each sample was duplicated with two No Template Control (NTC) for each probe used. 
The PCR reaction master mix was prepared for No. of reactions × 20 µl (excluding the 
cDNA).  
Reaction component Per reaction (ul) 
Taqman Universal Master Mix (2X) 12.5 
20X Assay Mix of Gene of Interest 1.25 
20X 18S RNA Assay Mix 1.25 
cDNA (total 100 ng) 5 
DEPC-treated Water 5 
Total 25 
 
20 µl of the master mix was pipetted to the bottom of each well of the optical 96-well fast 
reaction plate. 5 µl of cDNA or water (NTC) was added to the designated reaction well. 
The reaction plate was sealed with an Optical Adhesive Cover. The plate was then 
centrifuged at 4000 rpm for 5 min using the eppendorf centrifuge to eliminate air bubbles 
and force all solution to the bottom of well. The plate was then read by the 7000 Fast 
Real-Time PCR System with the following conditions: 











Temperature 50 °C 95 °C 95 °C 60 °C 
Time 2 min 10 min 15 s 1 min 
No. of cycles 1 1 40 
 
2.13 Microarray analysis 
2.13.1 Microarray experiment using Illumina Mouse Ref8 Ver.1.1 hybridization 
beadchips 
• Illumina® TotalPrep RNA Amplification Kit (Ambion) 
• Total RNA 
• RNase-free water 
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• streptavidin-Cy3 
• Hybridization and blocking buffers 
• streptavidin-Cy3 
 
500 µg total RNA sample was brought up to an initial start volume of 11 µl. RNA was 
reverse transcribed to form first strand cDNA with the T7 Oligo(dT) Primer to synthesize 
cDNA containing a T7 promoter sequence., which was subsequently used for the second 
strand cDNA synthesis (employs DNA polymerase and Rnase H to simultaneously 
degrade the RNA and synthesize second strand cDNA). The cDNA were purified to 
remove RNA, primers, enzymes, and salts that would inhibit in vitro transcription. 
Finally in vitro transcription is employed to generate multiple copies of biotinylated 
cRNA from the double-stranded cDNA templates. All the previously mentioned 
procedures were performed using Illumina® TotalPrep RNA Amplification Kit. The 
yield of cRNA was quantitated using the NanoDrop ND-1000. 
 
750 ng cRNA in a total volume of 5 µl RNase-free water was mixed with 10 µl 
hybridization buffer and preheated to 65 °C for 5 min. The assay sample was then fully 
loaded onto the large sample port of each array on the beadchip. After loading of all 
assay samples had been completed, the beadchip contained in the humified hybridization 
chamber was placed in the 58 °C oven for 17 h. The following day, the IntelliHyb seal on 
the beadchip was removed to expose all the arrays. The arrays underwent different buffer 
wash, blocked, labeled with streptavidin-Cy3 and dried. The beadchip was then ready for 
scanning on the Illumina scanner using Bead Studio software at Scan Factor = 0.8. 
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2.13.2 Microarray data collection and analysis 
Initial analysis of the scanned images was performed using BeadScan (Illumina). For 
absolute analysis, each chip was scaled to a target intensity of 1000-2000, and probe. The 
absolute data (signal intensity, detection call and detection P-value) were exported into 
GeneSpringGX 7.3 (Agilent Technologies, CA, USA) software for analysis by 
parametric test based on crossgene error model (PCGEM). 1 way ANOVA approach is 
been used to identify differentially expressed genes.  
 
Array data were globally normalized using GeneSpring software. Firstly, all of the 
measurements on each chip were divided by the 50
th
 percentile value (per chip 
normalization). Secondly, each gene was normalized to the baseline value of the control 
samples (per gene normalization) using median. Then genes were filtered on fold change 
1.5 fold against controls in at least one of 6 conditions to facilitate comparison between 
two cell death models, since for each respective treatment (NaHS and NMDA), 3 time-
points were assigned. Finally, 1 way ANOVA approach is been used to find differentially 
expressed genes (p <0.05). There are 6780 genes which were differentially expressed and 
they are annotated according to Gene Ontology- Biological process.  
 
2.14 Proteomics analysis using 2-DIGE 
2.14.1 Whole cell lysate harvesting 
• Lysis buffer  
• 10 mg/ml RNase stock 
• 10 mg/ml DNase stock 
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• 1 % (v/v) protease inhibitor cocktail (PIERCE HaltTM, #78415)  
• 22-gauge needle  
 
Lysis buffer containing 7 M urea (Bio-Rad, #161-0731), 2 M thiourea (Fluka, #88810), 4 
% (v/v) CHAPS (USB, #13361) and 10mM Tris (USB, #77-86-1) were prepared and 
stored in -80 °C. RNase stock of 10mg/ml RNase (Roche Diagnostic, #0109169), 0.5 M 
Tris-HCl (pH 8.8) top up with MilliQ water and DNase stock of 10 mg/ml DNase (Roche 
Diagnostic, #01040159), 1 M MgCl2, 0.5 M Tris-HCl (pH 8.8) top up with MilliQ water 
were also prepared. Both RNase and DNase stock (final concentration – 50 µg/ml) 
together with 1 % (v/v) protease inhibitor cocktail (PIERCE Halt
TM
, #78415) were added 
to the lysis buffer prior for use in whole cell lysate harvesting. 100µl of lysis buffer was 
used for the harvesting of every 3 wells (800 µl was needed for a 24-well plate culture). 
Samples collected in microfuge tubes were then homogenized by passing through a 22-
gauge needle 15 times each. After which, they were centrifuged at 50,000 rpm for 2 h at 
15 °C to remove lipids, microsomes and unwanted plasma membrane component and 
stored at -80 °C.  
 
2.14.2 Protein clean-up and quantification 
• 2D Clean-up kit (Amersham Biosciences, #80-6484-51) 
• Rehydration buffer (7M urea, 2M thiourea, 4% (v/v) CHAPS) 
• 2D Quant Kit (Amersham Biosciences, #80-6483-56) 
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Clean-up of protein samples was needed for the removal of interfering contaminants. 2D 
Clean-up kit (Amersham Biosciences, #80-6484-51) was used with instructions provided 
in the kit and samples were then re-suspended in small amount of buffer (7 M urea, 2 M 
thiourea, 4 % (v/v) CHAPS). Subsequently, 10 µl each of protein samples was used in 
protein concentration determination using the 2D Quant Kit (Amersham Biosciences, 
#80-6483-56), likewise with instructions provided in the kit.  
 
2.14.3 Sample Labeling with CyDye DIGE Fluors (minimal dye) 
• CyDye Fluors – Cy2, Cy3 and Cy5 (GE healthcare Biosciences #25-8008-60, 
#25-8008-61, #25-8008-62) 
• Dimethylformamide (DMF; Sigma, #22705-6) 
• pH indicator strips  
• 10 mM L-lysine (Sigma, #L-5626) 
 
CyDye Fluors – Cy2, Cy3 and Cy5 (10nM each) were purchased from GE healthcare 
Biosciences #25-8008-60, #25-8008-61, #25-8008-62. CyDye Flours were each dilute 
with dimethylformamide (DMF; Sigma, #22705-6) to form stocks of 1 nM/µl. Prior to 
sample labeling, pH indicator strips were used to check the pH of protein sample lysate. 
The ideal pH range will be from 8.0 - 8.5 to facilitate optimal labeling of the protein 
samples with the CyDye Flours. Protein samples with pH lower than 8.0 will be adjusted 
by careful addition of 50 mM sodium hydroxide (NaOH; Merck, #1.06498). 40 µg of 
controls and 40µg of treated protein samples across different time points will each be 
labeled with 320 pmoles (diluted from stock with DMF) of Cy3 and Cy5 respectively. An 
internal standard labeled with Cy2 was made by pooling equal amount of samples from 
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both batches of cell culture. The labeling reactions for all protein samples were carried 
out in an ice-bath and in the dark for 30 min. Each reaction was then terminated by 
adding 0.8 µl of 10 mM L-lysine (Sigma, #L-5626), follow by incubation on ice for 10 
min. After which, samples were then stored in -80 °C until 2D gel electrophoresis 
 
2.14.4 Rehydration of immobilized pH gradient (IPG) gel strips 
• Immobiline DryStrip 18 cm pH 3-10 non-linear (NL) IPG strip (Amersham 
Biosciences, #17-1235-01) 
• Immobiline DryStrip Reswelling Tray (Amersham Biosciences, #80-6465-32) 
• Rehydration buffer (7 M urea, 2 M thiourea, 4 % (v/v) CHAPS with traces of 
bromophenol blue) 
• Immobiline DryStrip cover fluid mineral oil (Amersham Biosciences, #17-1335-
01) 
 
Each Immobiline DryStrip 18 cm pH 3-10 non-linear (NL) IPG strip (Amersham 
Biosciences, #17-1235-01) was rehydrated faced down in Immoniline DryStrip 
Reswelling Tray (Amersham Biosciences, #80-6465-32) fill with 350 µl of rehydration 
buffer containing 7 M urea, 2 M thiourea, 4 % (v/v) CHAPS with trace amount of 
bromophenol blue. The strips were then cover with Immobiline DryStrip cover fluid 
mineral oil (Amersham Biosciences, #17-1335-01) to minimize evaporation and urea 
crystallization. Strips were then left rehydrated overnight.  
 
2.14.5 First Dimension – Isoelectric Focusing (IEF) 
• Ettan IPGphor II IEF unit (Amersham Biosciences) 
• Rehydration buffer (7 M urea, 2 M thiourea, 4 % (v/v) CHAPS, traces of 
bromophenol blue) 
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• 1 % (v/v) pH 3-10 NL IPG buffer 
• 0.5 % (v/v) 2M dithiothreitol (DTT, Sigma, #D9779) 
• Ettan IPGphor ceramic cup loading strip holder (Amersham Biosciences, #80-
6459-43) 
• Electrode pads (Amersham Biosciences, #18-1004-40) 
• Loading cup (Amersham Biosciences, #80-6459-81) 
 
IEF was run on rehydrated IPG strips using Ettan IPGphor II IEF unit (Amersham 
Biosciences). 40 µg each of samples from control (Cy3), treated (Cy5) and standard 
(Cy2) were mixed and topped up with rehydration buffer (7 M urea, 2 M thiourea, 4 % 
(v/v) CHAPS, trace amount of bromophenol blue), 1 % (v/v) pH 3-10 NL IPG buffer and 
0.5 % (v/v) 2M dithiothreitol (DTT, Sigma, #D9779) to a total volume of 25 µl. Gel strip 
rehydrated previously was first placed on the Ettan IPGphor ceramic cup loading strip 
holder (Amersham Biosciences, #80-6459-43) followed by the placement of moist 
electrode pads (Amersham Biosciences, #18-1004-40) at the both ends of the IPG strip. 
Electrodes (Amersham Biosciences, #80-6464-94) were then placed on the pads and 
loading cup (Amersham Biosciences, #80-6459-81) was placed beside the electrode at the 
positive end. Sample prepared were then loaded onto the loading cup and the strip was 
then covered with 4 ml of cover fluid mineral oil. IEF was run at the following 
parameters (see Table below) and strips were subsequently stored at -80 °C until second 




Conditions: IEF at 20 °C, 50 µA Max/strip 
Cycle Step and hold (S) 
or gradient (G) 
Voltage (V) Time (h) Voltage (V) / Volts-
hours (Vh) 
S1 S 200 2 400 V 
S2 S 500 1 500 V 
S3 S 1000 0.5 500 V 
S4 G 1000-8000 0.5 2250 Vh 
S5 S 8000 4.5 41333 Vh 
   Total: 8.5  
 
2.14.6 Second Dimension – SDS-PAGE 
• Equilibration buffer I (6 M urea, 50 mM Tris-HCl; pH 6.8, 2 % (w/v) SDS, 30 % 
(v/v) glycerol (J.T. Baker, #2136-1) and 1 % (w/v) DTT) 
• Equilibration buffer II (6 M urea, 50 mM Tris-HCl pH 8.8, 2 % (w/v) SDS, 30 % 
(v/v) glycerol and 2 % (w/v) iodoacetamide (IAA; Fluka, #57670) 
• 11 % 2D-SDS-PAGE gels (see constituents in Table below) 
• 1 % (w/v) agarose (Bio-Rad Laboratories, #163-2111 
 
Gel strips collected after IEF were equilibrated in a 2-step procedure. The strips were first 
equilibrated in 10 ml equilibration buffer containing 6 M urea, 50 mM Tris-HCl; pH 6.8, 
2 % (w/v) SDS, 30% (v/v) glycerol (J.T. Baker, #2136-1) and 1 % (w/v) DTT, followed 
by washing in 10 ml of equilibration buffer containing 6 M urea, 50 mM Tris-HCl pH 
8.8, 2 % (w/v) SDS, 30 % (v/v) glycerol and 2 % (w/v) iodoacetamide (IAA; Fluka, 
#57670). After which, the gel strips were transferred onto the pre-cast 2D-SDS-PAGE 
gels (see Table below) and sealed with 1 % (w/v) agarose (Bio-Rad Laboratories, #163-
2111 - dissolved in 1X Tris-glycine SDS-PAGE running buffer with trace amount of 
bromophenol blue). SDS-PAGE was carried out in 1.0 mm thick, 11 % polyacrylamide 
gel, ran in 4 litres of 1X running buffer (0.0025 M Tris, 0.0192 M glycine, 0.01 % (w/v) 
SDS , pH 8.3) using the PROTEAN-II XL electrophoresis cell. All gels were run in the 
dark at 10°C and at 15mA per gel for 20 min and subsequently at 30 mA per gel after. 
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Upon completion of electrophoresis, all gels with the glass plates unattached were 
wrapped in plastic sheets and kept in dark prior to image acquisition on the Typhoon 
9400 variable mode imager (GE Healthcare Biosciences).  
 
 
2.14.7 Image acquisition 
The gels were captured on Typhoon 9400 variable mode imager using the fluorescence 
scan acquisition mode at the following excitation/emission wavelengths 488/520 nm, 
532/580 nm, and 633/670 nm for Cy2, Cy3 and Cy5 respectively. Gels were scanned at 
pixel size of 100 microns and calibration was done using the first gel with instructions 
from the Ettan DIGE User Manual (18-1164-40 Edition A). Three images were obtained 
from each gel and that gives a total of 6 gel images per sample batch for a time-point-
specific treatment. A total of 12 gel images were obtained as 2 batches of samples were 
used. These images were then saved and analyzed using the DeCyder v 6.0 software (GE 




11 % gel – 40 ml / 1.0 mm-gel Constituents for casting 11 % 2D 
polyacrylamide gels 1 sample (ml) 2 samples (ml) 
MilliQ water 14.52 29.04 
30 % Acrylamide/Bis solution 14.68 29.36 
1.5 M Tris, pH 8.8 of resolving buffer 
(Final concentration - 0.375 M) 
10 20 
0.1 % (v/v) of 10 % SDS 0.4 0.8 
0.1 % (v/v) of 10 % APS 0.4 0.8 
0.05 % (v/v) of  TEMED 0.02 0.04 
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2.14.8 Image analysis 
DeCyder v 6.0 was used in the analysis of gel images based on instructions from the 
Ettan DIGE User Manual. Differential in-gel analysis (DIA) module was first used for 
spot detection and quantification, identifying an average of 4000 spots per gel.  Matched 
images were then analyzed using the biological variation analysis (BVA) module where 
differentially expressed spots, each with their statistical values obtained. All standard gels 
were carefully screened to confirm they matched one another so as to facilitate reliable 
comparisons across all gels.  Protein spots on gels were analyzed and compared using 
statistical tests such as Student’s T-test, One-way ANOVA and Average ratio and only 
differentially expressed protein spots (be it up or down) with ≥2 and ≤-2 fold difference 
between control and treated samples and with a statistical significance of p < 0.05 were 
selected. All these differentially expressed spots selected must also be consistently 
present in at least 9 out of all 12 gels. Confirmed spots were then excised from silver-
stained gels for identification using mass spectrometry (MS).  
 
2.14.9 Silver staining 
• Fixation solution (50 % (v/v) methanol, 12 % (v/v) acetic acid (Merck, #1.00063), 
0.05 % formalin (Sigma, #F1635)) 
• Washing solution (35 % (v/v) ethanol (Merck, #1.00983)) 
• Sensitization solution (0.02 % (w/v) sodium thiosulphate (Merck, #1.06516)) 
• Staining solution (0.2 % (w/v) silver nitrate (Merck, #1.01512), 0.076 % (v/v) 
formalin solution) 
• Developing solution (6 % (w/v) sodium carbonate (Merck, #1.06392) 0.004% 
(w/v) sodium thiosulphate, 0.05 % (v/v) formalin) 
• Stop solution (1.46 % (w/v) EDTA (Bio-Rad Laboratories, #161-0729)) 
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• Milli-Q water 
 
Cydye-labeled gels were silver stained using Vorum’s protocol (Mortz et al., 2001) but 
with some modifications. Gels were each fixed in 12 0µl of fixation solution, containing 
50 % (v/v) methanol, 12 % (v/v) acetic acid (Merck, #1.00063), 0.05 % formalin (Sigma, 
#F1635) in MilliQ water at 4 °C overnight. Following steps were carried out with gentle 
shaking and with 120 µl of solution each time unless otherwise stated. Fixed gels were 
washed three times in 35 % (v/v) ethanol (Merck, #1.00983) for 20 min each time before 
sensitization for 2 min with 0.02 % (w/v) sodium thiosulphate (Merck, #1.06516) 
solution. Subsequently, gels were washed three times with MilliQ water for 5 min each 
time before staining with 0.2 % (w/v) silver nitrate (Merck, #1.01512), 0.076%  (v/v) 
formalin solution for 20 min. After staining, gels were washed twice with MilliQ water 
for 1 min each time to rid off excess silver nitrate. Gels were then developed with 
solution containing 6 % (w/v) sodium carbonate (Merck, #1.06392) 0.004% (w/v) sodium 
thiosulphate, 0.05 % (v/v) formalin, with intense shaking. Upon desired intensity, 
developing reaction was stopped with 1.46 % (w/v) EDTA (Bio-Rad Laboratories, #161-
0729) for 20 min. Finally, gels were washed another three times for 5 min each time 
before images acquisition using UMAX ImageScanner (UMAX Technologies Inc.). 
Freshly stained gels were then kept at 4 °C until protein spot excision.  
2.14.10 In gel proteolytic digestion 
• 96-well polypropylene microtitre plate  
• wash buffer (2.5 mM ammonium bicarbonate (Sigma, #A6141), 5 0% (v/v) 
acetonitrile (ACN; Applied Biosystems, #40-4050-50)) 
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• Thermo Savant SPD Speed-vac SPD121P centrifugal concentrator (Holbrook, 
NY, USA)  
• Reducing solution (10 mM DTT in 100mM sodium bicarbonate) 
• Alkylating solution (55 mM IAA in 100 mM sodium bicarbonate) 
• Washing solution (100 mM ammonium bicarbonate) 
• Dehydration solution (100 % acetonitrile (ACN; Applied Biosystems, #40-4050-
50) 
• Trypsin solution (trypsin vial of 20 µg from Promega, #V5280 dissolved in 1000 
µl of 25 mM ammonium bicarbonate) 
• Extraction buffer (0.1 % (v/v) trifluoroacetic acid (TFA; Fluka, #09746) in 50 % 
(v/v) ACN) 
• 5 mg/ml of α-cyano-4-hydroxycinnamic acid (CHCA; Sigma, #C8982) matrix 
(dissolve in extraction buffer) 
 
Differentially expressed protein spots (< 96) previously identified were manually excised 
from the silver stained gels using a self-made plunger and placed into a 96-well 
polypropylene microtitre plate. The gel plugs were then washed with 150 µl of wash 
buffer (2.5 mM ammonium bicarbonate (Sigma, #A6141), 5 0% (v/v) acetonitrile (ACN; 
Applied Biosystems, #40-4050-50)) for 20 min before incubation in fresh wash buffer at 
4 °C for a minimum of 24 h. After incubation, old wash buffer were replaced with the 
same amount of fresh wash buffer before incubation with shaking at 37 °C for 10 min. 
This step was repeated twice before all solution was removed and gel spots on plate were 
dry with Thermo Savant SPD Speed-vac SPD121P centrifugal concentrator (Holbrook, 
NY, USA) for 5 min. The gel spots were first each reduced with 10 ul of 10 mM DTT in 
100mM sodium bicarbonate at 56 °C for 60 min and later alkylated with 20 ul of 55 mM 
IAA in 100 mM sodium bicarbonate in dark at room temperature for 45 min. After 
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which, solution was discarded and gel spots were each washed with 100 µl of 100 mM 
ammonium bicarbonate at 37 °C with shaking for 10 min before dehydration with same 
amount of 100 % ACN at room temperature for another 10 min. This step was repeated 
once before gel spots were speed vac to complete dryness for 10 min. 10 µl of trypsin 
solution (trypsin vial of 20 µg from Promega, #V5280 dissolved in 1000 µl of 25 mM 
ammonium bicarbonate) was subsequently added to each spot and incubated at 4 °C for 
30 min. Excess trypsin solution that was not absorbed by gel spot was then removed from 
each well, followed by the addition of 10 µl of 25 mM ammonium bicarbonate. Gel spots 
were then incubated at 37 °C without shaking for 16 h to facilitate trypsin enzymatic 
digestion. After which, peptide solution from each gel spot were collected in separate 
microfuge tubes and peptides were further extracted with sonication in 10µl of extraction 
buffer (0.1 % (v/v) trifluoroacetic acid (TFA; Fluka, #09746) in 50 % (v/v) ACN), each 
for 20 min in a sonicator water bath. Peptide solution obtained was then added to their 
respective previously collected peptide solution. Consolidated solution for each protein 
spot was then speed vac to dryness before the addition of 10 µl of extraction buffer each 
and speed vac to dryness. 5 mg/ml of α-cyano-4-hydroxycinnamic acid (CHCA; Sigma, 
#C8982) matrix (dissolve in extraction buffer) was prepared and used in the mixing of 
Maldi plate spotting matrix (2 % (v/v) 6 mg/ml ammonium citrate (Fluka, #09833), 98 % 
(v/v) 5mg/ml CHCA matrix). 1.2 µl of this spotting matrix was used to wash peptides in 
each microfuge tube and spotted onto the Maldi plate. Spots were then left to dry before 




2.14.11 Matrix-assisted Laser Desorption/Ionization Time of Flight/Time of Flight 
Mass Spectrometry (MALDI-TOF/TOF-MS) 
MS and MS/MS Spectra were obtained using the ABI 4800 Proteomics Analyzer 
MALDI-TOF/TOF Mass Spectrometer (Applied Biosystems) operating in a result –
dependent acquisition mode. For MS analysis, 2000 shots were accumulated for each 
well of sample. 6 external standards (mass standard kit for the 4700 Proteomics Analyzer 
calibration mixture, Part Number 4333504, Applied Biosystems) were used to calibrate 
each spectrum to a mass accuracy within 50 ppm. Ten most intense ions from each 
sample excluding trypsin autolysis and keratin tryptic peptides were selected for MS/MS. 
The MS/MS analyses were performed using air, at collision energy of 2 kV and a 
collision gas pressure ~1 x 10 
-6
 Torr. Stop conditions were implemented so that 2000 to 
3000 shots were accumulated depending on the quality of the spectra. GPS Explorer
TM  
software Version 3.6 (Applied Biosystems) was used to create and search files with 
MASCOT search engine (version 2.1; Matrix Science)  for peptide and protein 
identification.  International Protein Index (IPI) mouse database Version 3.2.6. was used 
for the search and was restricted to tryptic peptides. N-terminal acetylation, Cysteine 
carbamidomethylation and methionine oxidation were selected as variable modifications. 
One missing cleavage was allowed. Peptide mass tolerance and fragment mass tolerance 
were set to 150 ppm and 0.4 Da respectively. Maximum peptide rank was set to 2 and 





2.15 Statistical Analysis 
All experiments were repeated at least three times. Data were analyzed using Tukey test 
with one-way analysis of variance (ANOVA) to assess significant differences in multiple 
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3.1.1 Concentration-dependent decrease in cell viability of NaHS-treated neurons 
 
A recent study by Kimura and Kimura, 2004 demonstrated that H2S protected mouse 
primary neurons against glutamate-mediated oxidative stress through increasing 
intracellular glutathione levels. Following this trend of thought and on the basis of 
evidence furnished by this journal, we proposed to study the effects of H2S alone in our 
model system of mouse primary cortical neurons which comprises of 95 % neurons with 
minimal contamination by glial cells (Cheung et al., 1998). Neurons cultured on day 3 
and 7 in vitro were selected respectively for our study to ensure a thorough elucidation of 
the biological functions of H2S with respect to the age of the neurons, since perturbed 
H2S synthesis has been related to old-age-related neurodegeneration. It is important to 
keep in mind that the cultured neurons in our model system are differentiated post-mitotic 
cells. 
 
To our amazement, NaHS, a H2S donor, induce a contrasting cell survival effect between 
day 3 and day 7 cultured neurons after 24 h (Figure 3.1.1A). Day 3 neurons treated with 
escalating doses of NaHS demonstrated consistent cell viability comparable to control, a 
phenomenon which occurred irrespective of NaHS treatment. Instead, in sharp contrast, 
NaHS induced a dose-dependent reduction in cell viability as revealed by the MTT 
reduction assay with an EC50 of 200 µM (Figure 3.1.1A). Similarly, day 7 neurons when 
treated with NaHS concentrations less than 200 µM showed no significant LDH release 
(Figure 3.1.1B). Upon treatment with NaHS doses above 200 µM, LDH release was 
significantly elevated, an indication of neurons undergoing necrotic cell death (Figure 



































































Figure 3.1.1 Concentration-dependent decrease in cell viability observed NaHS-treated day 7 neurons.  
Cells were exposed for 24 h to NaHS at the stated concentrations and cell viability analyzed by (A) MTT 
and (B) LDH assays. Data are expressed as Mean ± S. D. of 6 or more separate determinations. ***p < 
0.001 compared to control neurons. 
 
 *** 
***   ***   *** 
 *** 




3.1.2 Induction of apoptosis by NaHS on day 7 mouse primary cortical neurons 
H2S-induced neuronal death in day 7 neurons was further substantiated by morphological 
analysis. Higher concentrations of NaHS (500 µM – 1 mM) induced cell swelling of 
treated neurons within 8 h exposure (Figure 3.1.2A) and extensive degradation of the 
neurite network and lysis, a more in-depth demonstration of necrotic cell death. However, 
treatment of day 7 neurons with lower concentrations of NaHS (< 200 µM) did not 
induce significant morphological changes within 8 h when compared with non-treated 
control (Figure 3.1.2A). Rather, within 24 h of administration, neurons treated with 200 
µM NaHS revealed typical signs of apoptosis including shrinkage of neuronal cell body 
and cell body shrinkage (Figure 3.1.2B).  Furthermore, double-staining with Hoechst 
33342 and propidium iodide (PI) to ascertain whether cell death induced by low dose of 
NaHS was apoptotic revealed that at 24 h post-treatment, severely damaged cells were 
represented by condensed chromatin emitting blue and red fluorescence were more 
prevalent in the neurons treated with 500 µM and 1 mM NaHS as compared to the 
control and 200 µM NaHS-treated neurons (Figure 3.1.2C). Opposed to this, Day 7 
neurons when treated with NaHS concentrations < 200 µM though showed condensed 
chromatin but with intact plasma membranes (PI negative; Figure 3.1.2C) and no 
significant LDH release (Figure 3.1.1B), highly demonstrative of apoptotic cell death 
induced by 200 µM NaHS.  
 
To allow further affirmation of H2S induction of apoptotic death at 200 µM NaHS, we 
analyzed phosphatidylserine (PS) externalization using a commercial annexin V binding 
assay of a very slow time course. Figures 3.1.2D and 3.1.2E showed that substantial PS 
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externalization was observed after treatment of day 7 neurons with 200 µM NaHS for 15 
h (Figure 3.1.2D) when compared with untreated controls (Figure 3.1.2E; substantial 
confirmatory evidence of apoptotic neuronal death. (Data published in Cheung et al., 
2007) 
Figure 3.1.2 Time and concentration-dependent effects of NaHS on cellular morphology, DNA chromatin 
condensation, plasma membrane damage. NaHS was added at the concentrations stated and morphology 
was examined after 8 h (A) and 24 h (B). Double staining with Hoescht 33342 and propidium iodide was 
used to observe chromatin condensation and integrity of the plasma membrane respectively after 24 h (C). 
Phosphatidylserine externalization was assessed using a very slow timecourse Annexin V binding in 
untreated (D) and NaHS treated cells (200 µM, 15 h) (E). 
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3.2.1 Potentiation of L-glutamate-induced toxicity upon H2S application 
 
After having ascertained that sole application of NaHS induced neuronal apoptosis in day 
7 neurons but not that of day 3 neurons, we then move on to determine if co-application 
of NaHS would confer any effects on glutamate-induced neuronal excitotxicity, since 
Kimura and Kimura, 2004 have reported neuroprotective effect conferred by H2S in 
glutamate-mediated neuronal death even in high doses of up to 1 mM. Excess L-
glutamate stimulation is known to induce cytotoxicity. However, intriguingly, in day 3 
neurons, 100 µM glutamate treatment was unable to cause any significant cell death 
(Figure 3.2.1). Furthermore, day 3 neurons were protected against cytotoxicity upon co-
application of both L-glutamate and NaHS at 100 and 25 µM respectively (Figure 3.2.1).  
 
Instead, in day 7 neurons, sole administration of 100 µM glutamate demonstrated a 
significant reduction of more than 50 % in cell viability (Figure 3.2.1). Moreover, even 
though low dose of NaHS (25 µM) was insufficient neuronal death in mature day 7 
neurons, a co-application of this amount with 100 µM L-glutamate (25 % cell viability) 
significantly potentiated death by approximately 20 % as compared to that of L-glutamate 
alone (48 % cell viability) (Figure 3.2.1). This demonstrated that H2S was capable of 
potentiating neuronal death when administered with L-glutamate, though alone was not 
capable of causing neurotoxicity indicating H2S worked synergistically with L-glutamate 














































Figure 3.2.1 Potentiation of L-glutamate-mediated neurotoxicity by NaHS application was seen only in day 
7 neurons.  Neurons were exposed to the stated conditions for 24 h and cell viability assessed by MTT 
reduction assay. Data are expressed as Mean ± S. D. of 6 or more separate determinations. ***p < 0.001 
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3.2.2 Differential expression of glutamate receptors in mouse primary cortical neurons 
in vitro 
 
As previous MTT data demonstrated that 100 µM glutamate treatment was able to induce 
neuronal death in day 7 but not day 3 neurons, we speculate that this difference might 
arise due to the differential expression of the GluRs with respect to the maturity of the 
neurons. Indeed, Western blotting performed on day 1 to day 8 cultured mouse primary 
cortical neurons revealed the absence of AMPA and NMDA receptor expression in day 1 
- 4 cultured mouse primary cortical neurons, as depicted by the lack of GluR2/4 (AMPA) 
and NMDA receptor 1 expressions respectively (Figure 3.2.2). These neurons without 
expression of GluRs are denoted as immature neurons. From day 5 cultures, neurons 
showed initial expression of AMPA and NMDA receptors with maximum expression 
optimized at day 7 and 8 (Figure 3.2.2). As such, neurons with full expression of GluRs 
are known as mature neurons. This explains the difference in response to cell viability in 
day 3 and 7 neurons upon glutamate induction. (Data published in Cheung et al., 2007) 
 
Figure 3.2.2 Differential expression of GluRs (GluR2/4-AMPA receptors; NMDA R1-NMDA receptors) 
in cultured mouse primary cortical neurons from day 1-8 in vitro.  Cultures of mouse embryonic day 15-16 
cortical neurons were cultured in Neurobasal medium with B-27 and GlutaMAX supplements for up to 8 
days in vitro. During this time cells were lysed and analyzed by western blotting for GluR 2/4 and NMDA 
R1 receptor expression. 10 µg of proteins was loaded per lane. Data are representative of 3 or more 
immunoblots. 
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3.2.3 NMDA and KA receptors implicated in H2S-mediated neuronal death 
To determine which GluR subtypes were involved in the mediated of H2S-induced 
neurotoxicity, various GluR subtype antagonists were employed to assess their 
effectiveness in attenuating H2S-mediated neuronal death. Only application of 
pharmacological NMDA receptor antagonists, MK801 and APV, and KA receptor 
antagonist, CNQX was the neurotoxic effect of 200 µM NaHS treatment able to be 
substantially attenuated, suggesting the importance of NMDA and KA receptor activation 
in the triggering of H2S-mediated signaling pathway (Figure 3.2.3). However, since 
NMDA receptors is the major ionotropic GluR subfamily and that its role has been 
implicated in neurodegenerative disorders such as stroke, AD, ischemia which overlap 
that of H2S, the role of NMDA receptors pertaining in relation to H2S-induced 
neurotoxicity would be our main focus of study. Involvement of KA receptors, which are 
potentially related to temporal lobe seizures, would be investigated in the future. As such, 
it would be more appropriate to employ the usage of the specific pharmacological agent, 
N-methyl-D-aspartate (NMDA) specific for NMDA receptor stimulation in subsequent 
experiments to allow valid comparison between NMDA- and H2S-triggered neuronal 
deaths. (Data published in Cheung et al., 2007) 
 
As NMDA receptor function has been reported to be regulated by extracellular pH 
(Traynelis et al., 1995), control experiments were performed whereby NaHS was added 
to culture media and pH measured using a standard pH meter. The addition of NaHS at 
the concentrations used above did not significantly alter the pH of the culture media used 
(data not shown). 
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Figure 3.2.3 Successful attenuation of H2S-induced neuronal death by NMDA and KA receptor 
antagonists. Highlight of the crucial role of NMDA and KA receptors in the mediation of H2S-induced 
neurotoxicity.  Mature day 7 neurons were treated with respective antagonists (10 µM) for 1 h prior to the 
addition of 200 µM NaHS and incubated 24 h. Data are expressed as Mean ± S. D. of 6 or more separate 


















3.2.4 Dose-dependent decrease in cell viability in NMDA-treated neurons 
 
To determine if the mechanism of neuronal death induced by H2S was related to NMDA 
receptors, the EC50 for activation of NMDA must be ascertained to facilitate subsequent 
valid comparisons between these two modes of cell death.  NMDA was applied to mature 
day 7 mouse primary cortical neurons. A dose-dependent reduction in cell viability was 
observed (Figure 3.2.4), which further substantiated previous finding of full expression of 
NMDA receptors in day 7 neurons (Figure 3.2.2). The EC50 for NMDA after 24 h period 





















Figure 3.2.4 Dose-dependent decrease in cell viability of NMDA-treated mature day 7 neurons. Cells were 
exposed for 24 h with NMDA at the stated concentrations and cell viability analyzed by MTT. Data are 
expressed as Mean ± S. D. of 6 or more separate determinations. *p <0.05, **p <0.01, ***p < 0.001 
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3.2.5 Calpain activation observed in H2S- and NMDA-mediated neuronal death 
 
A time-course analysis of 200 µM NMDA and NaHS-treated neurons demonstrated that 
calpains activation is predominant from early 5 h post-treatment in both models of 
neuronal death (Figure 3.2.5). Calpains, a highly conserved family of Ca
2+
-dependent 
proteases, are well known for their roles in excitotoxicity and apoptosis. Alpha-fodrin, a 
common substrate to both calpains and caspase-3, is frequently adopted as a marker to 
indicate respective proteases activation. An expression of 145/150 kDa protein fragments 
indicates cleavage of alpha-fodrin by activated calpains. Activation of caspase-3 is 
indicated by the presence of the 120 kDa cleaved fragment.  Absence of caspase-3 
activation in NMDA and NaHS-treated neurons was further substantiated by the lack of 
the 17 kDa caspase-3 subunit expression (Figure 3.2.5). Caspase-3, commonly seen in 
cells undergoing apoptosis comprises of a 17 kDa and an 11 kDa subunits which are 
originated from its 32 kDa precursor procaspase-3 by cleavage at multiple aspartic acid 
sites. This demonstrated that H2S-mediated neurotoxicity might share similar signaling 
pathway as that of NMDA, and as such the H2S molecule stimulated activation of NMDA 





Figure 3.2.5 NMDA and NaHS-treated neurons demonstrated significant cleavage of alpha-fodrin to 
145/150 kDa fragments, an indication of calpains activation. Absence of the 120 kDa alpha fodrin fragment 
in both treatments with no active cleaved caspase-3 expression demonstrated that both modes of neuronal 
death were caspase-independent. Lactacystin, a proteasomal inhibitor well established for inducing 
caspase-3-dependent apoptosis in neurons was used as a positive control. Neurons were treated with 1 µM 
lactacystin, and 200 µM NMDA and NaHS respectively and incubated at the stated time-points. After 
which neurons were lysed and used for Western blotting. 10 µg of proteins was loaded per lane. Data are 

























Chapter 3: Results 
 
3.3 Global Gene Profiles 
of 
H2S- and NMDA- 














3.3. Time-dependent differential gene expression profile in NaHS- and NMDA-treated 
mouse primary cortical neurons as revealed by microarray analyses 
Since this is the first time that H2S has been demonstrated to induce neuronal death and 
associated with GluRs particularly NMDA receptors, and there are no existing precedent 
literature to propose its possible signaling mechanism, employment of microarray 
technique is the most appropriate method to decipher H2S-mediated signaling cascade 
upon induction of neuronal apoptosis. It serves as a screening method to reveal the global 
gene profile at different time phases of H2S-induced death, as well as permit comparison 
of this data against that of NMDA receptor-triggered death This is of utmost importance 
as it disclosed the role of NMDA receptor in the H2S induction of neuronal death, and the 
extent of overlap of these two cell death models. Microarray analyses using Illumina 
Mouse Ref8 V1.1 beadchips revealed differential global gene regulation over time in 
NaHS- and NMDA-treated mouse primary cortical neurons. Out of a total of 24, 613 
well-annotated RefSeq transcripts, 6, 780 genes were differentially expressed more than 
1.5 fold change in any of the 6 specific condition - time-points (NaHS: 5 h, 15 h and 24 
h; NMDA: 5 h, 15 h and 24 h) according to the one-way ANOVA, p<0.01 and had 
passed the Benjamini-Hochberg False Discovery Rate (FDR) Correction. FDR a 
commonly adopted statistical analysis, controls the proportion of the most relevant errors 
among those tests whose null hypothesis were rejected and possesses higher power than 
Bonferroni Correction. Among these 6, 780 genes, only 50 genes passed the Bonferroni 
Correction. The Bonferroni Correction was applied as a very stringent statistical mean to 
reduce false positive or genes for which a statistically significant difference is observed 
when there is in fact no difference, was carried out. Bonferroni seeks to control the 
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chance of even a single false discovery among all tests performed. Genes with more than 
1.5 fold change were then subjected to clustering by the online DAVID Bioinformatics 
Resources 2007 database, using the gene functional classification tool. Genes were 
grouped according to their Gene Ontology-Biological processes based on updated 
literature findings. In this study, we will focus on cell death-related gene families induced 
in H2S-mediated neuronal apoptosis, with simultaneously comparison to NMDA-
mediated neuronal death.  
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3.3.1 Differential gene expression of genes encoding proteins involved in apoptosis 
 
Significant up-regulation of apoptotic genes such as Bag3, Angptl4 and Casp-6 was 
observed at the 15 h NaHS post-treatment, with maintenance of high gene expression 
even in the late phase (24 h) of H2S-mediated neuronal death. Similar up-regulation trend 
in these genes was also observed in NMDA-treated neurons, but was demonstrated to 
occur at an earlier time-point of 5 h (Table 3.3.1). 
 
Consistent down-regulation of Casp-3, -9, Bad and Cycs gene expressions was observed 
in both models of neuronal death (Table 3.3.1). This is unsurprising as these genes 
encode proteins involved in mitochondrial-dependent caspase-3-mediated apoptosis, and 
previous immunoblot analysis revealed a lack of caspase-3 activation in H2S- and 
NMDA-induced death model (Figure 3.2.5). Furthermore, caspase-9 and Bad being 
apoptosis executioners downstream of caspase-3 would naturally remain inactivated. This 
fully supported the notion that H2S-mediated neuronal death was caspase-3-independent.
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Table 3.3.1 Gene expression profiles of genes encoding proteins involved in apoptosis in cultured day 7 mouse 
primary cortical neurons treated with 200 µM NaHS and NMDA respectively. Data are expressed as fold-change 
± SE. 
Genbank Gene Title Symbol Time-points (hours) 
  200 uM NaHS 200 uM NMDA 
Apoptosis  5 h 15 h 24 h 5 h 15 h 24 h 
NM_013863 




























































Caspase 3 apoptosis related 





























































































































3.3.2 Differential gene expression of genes encoding proteins involved in endoplasmic 
reticulum (ER) stress 
Significant increase in gene expression in members of the cathepsins family (cathepsin B, 
C and Z; Table 3.3.2) was observed in in NaHS- and NMDA treatment, with the former 
demonstrating an up-regulation at the late 24 h phase, and the latter inducing an elevation 
as early as 5 h as shown in cathepsin C and at 15 h for cathepsin B and Z.  Taking into 
consideration of previously demonstrated early calpains activation at 5 h (Figure 3.2.5), 
this indicates the highly likely occurrence of the calpains-cathepsin phenomenon within 
the neurons in both treatment models. 
 
Furthermore, a significant transcriptional elevation of other severe ER stress-induced pro-
apoptotic genes comprising DNA-damage inducible transcript 3 (Ddit3) and 
CCAAT/enhancer binding protein (C/EBP) beta (Cebpb), was observed at 24 h in H2S-
mediated neuronal death. Dimerization of Ddit3 protein with its partner, Cebpb protein, 
forms a repressor complex which inhibits transcription of survival-promoting genes. Thus 
in NaHS treatment, increase in Cebpb gene expression correlated with rise in Ddit3 
mRNA level to suppress cell survival signaling cascade, as shown in Table 3.3.2. In 
contrast, in NMDA treatment, though a substantial rise in Cebpb gene expression was 
observed from 5 h, no significant differential gene regulation was observed in Ddit3.
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Significant increase in gene expression in members of the cathepsins family (cathepsin B, 
C and Z (Ctsb, Ctsc, and Cysz); Table 3.3.2) was observed in in NaHS- and NMDA 
treatment, with the former demonstrating an up-regulation at the late 24 h phase, and the 
latter inducing an elevation as early as 5 h as shown in cathepsin C and at 15 h for 
cathepsin B and Z.  Taking into consideration of previously demonstrated early calpains 
activation at 5 h (Figure 3.2.5), this indicates the highly likely occurrence of the calpains-
cathepsin phenomenon within the neurons in both treatment models. 
 
Table 3.3.2. Gene expression profiles of genes encoding proteins involved in endoplasmic reticulum (ER) 
stress in cultured day 7 mouse primary cortical neurons treated with 200 µM NaHS and NMDA respectively. 
Data are expressed as fold-change ± SE. 
Genbank Gene Title Symbol Time-points (hours) 
  200 uM NaHS 200 uM NMDA 
ER stress  5 h 15 h 24 h 5 h 15 h 24 h 
NM_007837 
DNA-damage inducible 








































































































3.3.3 Differential gene expression of genes encoding proteins involved in calcium 
homeostasis and binding 
Genes encoding for proteins involved in calcium homeostasis and binding were 
significantly up-regulated in H2S- and NMDA-mediated neuronal deaths (Table 3.3.3). 
 
In NaHS treatment, substantial gene up-regulation was observed from as early as 5 h for 
S100 calcium binding protein A6 (S100a6) and Annexin A3 (Anxa3), mid-phase (15 h) 
for S100 calcium binding protein A1 (S100a1) and Annexin A2 (AnxA2) and late-phase 
(24 h) for S100 calcium binding protein A4 and A13 (S100A4, S100A13) and Annexin 
A5 (AnxA5).   
 
In NMDA treatment, significant increase in gene expression for all genes was 
demonstrated at 15 h, with the exclusion of AnxA2 which showed early (5 h) up-
regulation (Table 3.3.3). Nevertheless, it could be concluded that consistent gene up-



















Table 3.3.3 Gene expression profiles of genes encoding proteins involved in calcium homeostasis and binding in 
cultured day 7 mouse primary cortical neurons treated with 200 µM NaHS and NMDA respectively. Data are 
expressed as fold-change ± SE. 
Genbank Gene Title Symbol Time-points (hours) 
   200 uM NaHS 200 uM NMDA 
 Calcium homeostasis and binding  5 h 15 h 24 h 5 h 15 h 24 h 
NM_011309 












































S100 calcium binding 




































































































3.3.4 Differential gene expression of genes encoding proteins involved in cell survival 
As shown by microarray analysis in Table 3.3.4, only Igf2 gene expression showed 
significant elevation at 15 h in NaHS treatment; up-regulation of Bdnf and Igf2 gene 
expressions was observed at 15 h in NMDA-treated neurons. However, other genes 
encoding protein molecules involved in promoting cellular survival demonstrated a 
pursuing down-regulaton trend at various phases of neuronal death induced by H2S and 
NMDA. These genes comprised of Mapk1, Vegfa, and Gsk3b. This suggested that the cell 
survival signaling cascades were being suppressed in the both death models. 
Table 3.3.4. Gene expression profiles of genes encoding proteins involved in cell survival in cultured day 7 mouse 
primary cortical neurons treated with 200 µM NaHS and NMDA respectively.  Data are expressed as fold-change ± 
SE. 
Genebank Gene Title Symbol Time-points (hours) 
  200 uM NaHS 200uM NMDA 
Cell survival  5 h 15 h 24 h 5 h 15 h 24 h 
NM_010514 












































Mitogen activated protein 




















Vascular endothelial growth 











































Platelet derived growth factor 











































3.3.5 Differential gene expression of genes encoding proteins involved in mitotic cell cycle 
regulation 
Post-mitotic cells destined for death sometimes switch on the cell cycle pathway as a pro-
proliferative resort to reverse the cell death machinery. As shown in Table 3.3.5, 
microarray analysis revealed genes which impede cell cycle re-activation, such as 
Gadd45g and p53 (also known as trp53) gene expression showed an up-regulation at 24 h 
and 15 h in both NaHS and NMDA treatment models respectively. Furthermore, genes 
crucial for cell cycle progression, such as Ccnd1 and E2f1 demonstrated significant 
down-regulation. 
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Table 3.3.5. Gene expression profiles of genes encoding proteins involved in mitotic cell cycle regulation in cultured 
day 7 mouse primary cortical neurons treated with 200 µM NaHS and NMDA respectively. Data are expressed as fold-
change ± SE. 
Genebank Gene Title Symbol Time-points (hours) 
   200 uM NaHS 200 uM NMDA 
Mitotic Cell Cycle  5 h 15 h 24 h 5 h 15 h 24 h 
NM_007891 






























































































































Cell division cycle 2-like 1, 












































Growth arrest and DNA-






















Transformation related protein 























Transformation related protein 






























































* denotes protein picked up by Bonferroni Correction. 
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3.3.6 Differential gene expression of genes encoding heat shock proteins (Hsps) and 
chaperones 
The elevation of cytosolic Ca
2+
 can trigger the production of ROS (McCullough et al., 
2001). As such, in response to the cellular oxidative stress, substantial increase in the 
transcriptional expression of numerous genes which encode for proteins involved in anti-
oxidant response were induced as a mechanism of counteraction in H2S- and NMDA-
mediated neuronal death (Table 3.3.6). These genes comprised of sulfiredoxin 1 
(Srxn1/Npn3), glutathione peroxidase 1 (Gpx1), Hsp27 (Hspb8), Hsp47 (Serpinh1) and 
metal ion chaperones, metallothionein 3 (Mt3). In H2S-mediated neuronal apoptosis, 
these genes were up-regulated from the 15 h phase, while in NMDA-mediated neuronal 















Table 3.3.6 Gene expression profiles of genes encoding heat shock proteins (Hsps) and molecular chaperones in 
cultured day 7 mouse primary cortical neurons treated with 200 µM NaHS and NMDA respectively. Data are 
expressed as fold-change ± SE. 
Genbank Gene Title Symbol Time-points (hours) 
  200 uM NaHS 200 uM NMDA 
Heat shock proteins and molecular chaperone  5 h 15 h 24 h 5 h 15 h 24 h 


















































































































































Serine (or cysteine) proteinase 






























































3.3.7 Differential gene expression of genes encoding proteins involved in ubiquitin-
proteasome system (UPS) 
The ubiquitin proteasome system (UPS) is a multi-step eukaryotic protein quality control 
system, where aberrant proteins are molecularly marked with poly-ubiquitins and hence 
are destined for degradation in the proteasome. The genes encoding ubiquitins and 
proteasome subunits were only highly down-regulated in the late phase (24 h) of H2S-
mediated neuronal death. These genes include those encoding for the proteasome 
subunits (Psmb5, Psmb10, Psmc2, Psmc5), ubiquitin-activating enzyme E1 (Ube1a, 
Ube1x), ubiquitin-conjugating enzyme E2 (Ube2n, Ube2i, Ube1v1) and ubiquitin-specific 
proteases (Usp10, Usp14, Usp20, Usp29) (Table 3.3.7). The late phase transcriptional 
down-regulation of UPS-related genes suggested that dysfunction of UPS is a 
downstream consequential event of H2S-mediated neuronal death. 
 
In NMDA-mediated neuronal excitotoxic death, majority of the genes encoding proteins 
involved in the UPS demonstrated no significant gene regulation with only a few 
exceptions comprising Ube1x, Ube2q, Uchl1, Usp5 and Usp14 with significant down-
regulation at 15 h, and Psmb5, Psmc1, Psmd5 and Rbx1 at 24 h. Nevertheless, genes 








Table 3.3.7 Gene expression profiles of genes encoding proteins involved in ubiquitin-proteasome system (UPS) in 
cultured day 7 mouse primary cortical neurons treated with 200 µM NaHS and NMDA respectively. Data are 
expressed as fold-change ± SE. 
Genbank Gene Title Symbol Time-points (hours) 
  200 uM NaHS 200 uM NMDA 
Ubiquitin-proteasome system  5 h 15 h 24h 5 h 15 h 24 h 
NM_011971 
Proteasome (prosome macropain) 





















Proteasome (prosome macropain) 





















Proteasome (prosome macropain) 





















Proteasome (prosome macropain) 





















Proteasome (prosome macropain) 26S 





















Proteasome (prosome macropain) 26S 





















Proteasome (prosome macropain) 26S 





















Proteasome (prosome macropain) 26S 





















Proteasome (prosome macropain) 26S 





















Proteasome (prosome macropain) 26S 











































Ubiquitin-like 1 (sentrin) activating 





















Ubiquitin-conjugating enzyme E2D 3 





















Ubiquitin-conjugating enzyme E2E 2 





















Ubiquitin-conjugating enzyme E2G 1 











































Table 3.3.7 (Cont’d). Gene expression profiles of genes encoding proteins involved in ubiquitin-proteasome system 
(UPS) in cultured day 7 mouse primary cortical neurons treated with 200 µM NaHS and NMDA respectively. Data are 
expressed as fold-change ± SE. 
Genbank Gene Title Symbol Time-points (hours) 
   200 uM NaHS 200 uM NMDA 
Ubiquitin-proteasome system  5 h 15 h 24h 5 h 15 h 24 h 
NM_027315 
Ubiquitin-conjugating enzyme E2Q 












































Ubiquitin protein ligase E3C, mRNA 

































































Ubiquitin specific protease 5 

































































































































































































3.3.7.1 Comparison of global gene profiles between H2S-, NO- and lactacystin-
mediated neuronal deaths 
It has been reported that NO released from a NO donor increases H2S production 
speculated to be through CSE/CBS induction or activation (Hosoki et al., 1997) and 
regulates smooth muscle tone in synergy with H2S (Zhao et al., 2001). As such, it can be 
inferred that the regulation of biological functions of NO and H2S is interrelated and that 
both neuromodulator inductions possibly share or converge to the same signaling 
cascades.  
 
Proteasome inhibitors have been used widely in the study of UPS in mammalian cells. In 
our previous study, a classical proteasome inhibitor, lactacystin, was used to induce cell 
death (Choy and Cheung, 2007) and its microarray results was taken as reference for 
comparison  
 
A cross comparison of microarray data among NaHS, NOC-18 (NO donor) and 
lactacystin-treated mouse primary neurons revealed that the genes encoding core 
components of the UPS, such as proteasome subunits Psma-Psmd, were down-regulated 
in NaHS-treated neurons, with significant reduced expression occurring at the late 24 h 
time-point when compared to the highly up-regulated expression lactacystin-treated 
samples (with Students’t-test p<0.01) over a 24 h time-course (Table 3.3.7.1). No 
significant differential expression of Psmb-Psmd was observed in NO-mediated 
apoptosis. Other UPS-related genes such as ubiquitin-conjugating enzymes E2 (Ube) and 
ring-box 1 (Rbx1) in H2S-mediated neuronal death showed marked down-regulation,  
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particularly at the 24 h post-treatment, a trend similarly observed in NOC-18 treated 
neurons. Genes encoding for ubiquitin-specific proteases also demonstrated decreased 
expression in neuronal death induced by H2S (Table 3.3.7.1) and NO (Peng et al., 2008), 
in contrast to significant upregulation in that of lactacystin (Choy and Cheung, 2007). 
This could be inferred that UPS dysfunction is a consequential event in H2S and NO-

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.3.8 Differential gene expression of genes encoding water and ion channels associated with 
apoptotic volume decrease (AVD) 
Gene expression of AVD-related ion and water channels involved in chloride, potassium 
and sodium transport demonstrated a consistent down-regulatory trend throughout the time 
course of H2S-mediated apoptosis with the most significant differential expression at 24 h 
in NaHS treatment and at 15 h in NMDA treatment (Table 3.3.8), suggestive of an 
occurrence of apoptosis in the absence of AVD. It has been shown in numerous cases that 
AVD is not a universal feature of apoptosis, though its occurrence is accounted for in 
majority of apoptotic mode of cell death.  
 
The absence of AVD was further supported by the increase in transcriptional expression of 
Atp1a2 and tpcn1 at 24 h and 15 h in NaHS and NMDA treatments, in which the proteins 




 homeostasis during 
apoptosis, and that in event of AVD, a loss of these protein function is naturally required 











Table 3.3.8. Gene expression profiles of genes encoding water and ion channels associated with apoptotic 
volume decrease (AVD) in cultured day 7 mouse primary cortical neurons treated with 200 µM NaHS and 
NMDA respectively. Data are expressed as fold-change ± SE. 
Genbank Gene Title Symbol Time-points (hours) 
   200 uM NaHS 200 uM NMDA 
     5 h 15 h 24 h 5 h 15 h 24 h 
Chloride transport        
NM_033444 






















Chloride channel 3 (Clcn3) 





















Chloride channel 3 (Clcn3) 







































Potassium transport        
NM_008435 
K+ voltage-gated channel 











































Potassium channel subfamily K 





















Potassium channel subfamily K 






















































































































































































Table 3.3.8 (Cont’d). Gene expression profiles of genes encoding proteins water and ion channels associated with 
apoptotic volume decrease (AVD) in cultured day 7 mouse primary cortical neurons treated with 200 µM NaHS and 
NMDA respectively. Data are expressed as fold-change ± SE. 
Genbank Gene Title Symbol Time-points (hours) 
   200 uM NaHS 200 uM NMDA 
   5 h 15 h 24 h 5 h 15 h 24 h 
Potassium transport        
NM_010603 
Potassium inwardly-rectifying 






















Potassium large conductance 
calcium-activated channel 






















Potassium large conductance 
pH-sensitive channel subfamily 





















Potassium large conductance 
calcium-activated channel 






















Potassium voltage-gated channel 
shaker-related subfamily beta 





















Potassium voltage-gated channel 
shaker-related subfamily beta 





















Potassium voltage-gated channel 
shaker-related subfamily 





















Potassium voltage-gated channel 






















Potassium voltage-gated channel 





















Potassium voltage-gated channel 
subfamily H (eag-related) 





















Potassium voltage-gated channel 
subfamily H (eag-related) 




















Sodium transport        
NM_011322 
Sodium channel voltage-gated 





















Sodium channel voltage-gated 





















Sodium channel voltage-gated 





















Table 3.3.8 (Cont’d). Gene expression profiles of genes encoding proteins water and ion channels associated with 
apoptotic volume decrease (AVD) in cultured day 7 mouse primary cortical neurons treated with 200 µM NaHS and 
NMDA respectively. Data are expressed as fold-change ± SE. 
Genbank GeneTitle Symbol Time-point (hours) 
  200 uM NaHS 200 uM NMDA 
  5 h 15 h 24 h 5 h 15 h 24 h 
Potassium/sodium transport        
NM_178405 ATPase Na+/K+ transporting 































































3.4. Validation of microarray analysis results by real-time PCR, Western blotting, 
Proteomics and Acridine Orange Re-distribution analyses 
 
Since microarray method only offers a global preliminary screening of genes regulated in 
H2S-mediated neuronal apoptosis with the potential for errors, it is important to validate 
individual gene regulatory profiles using probes specific for each gene/ protein expression. 
Taking into consideration the importance of confirmation of each gene regulation before a 
complete proposal of H2S-mediated signaling cascade can be established, various 
laboratory methods are performed to allow this validation.  
    
3.4.1 Validation of microarray analysis via real-time PCR 
Real-time PCR using gene-specific probes performed on the same H2S-treated neuronal 
samples used in microarray analysis on the above selected genes demonstrated a highly 
similar regulatory trend at the 15 h and 24 h (Table 3.4.1). Real-time PCR is a well-
established technique which has been frequently adopted to detect specific gene regulation 
due to its high precision and accuracy. This implied that the microarray data obtained are 
reliable for further analysis.   
Table 3.4.1. Validation of microarray data using real-time PCR technique on cultured day 7 mouse primary 
cortical neurons treated with 200 µM NaHS. Data are expressed as fold-change ± SE. 
Gene Title Symbol Microarray Real-time PCR (Gene 
Expression) 
  15 h 24 h 15 h 24 h 
Growth arrest and DNA-
damage-inducible 45 gamma 
Gadd45g 1.30 ± 0.48 2.50 ± 0.64 1.70 ± 0.88 1.64 ± 0.66 
Angiopoietin-like 4 Angptl4 1.57 ± 0.93 2.62 ± 0.69 62.62 ± 1.23 393.43 ± 0.88 
DNA damage-inducible 
transcript 3 
Ddit3 -1.26 ± 0.19 1.59 ± 0.41 -1.89 ± 0.65 3.24 ± 0.83 
Heme Oxygenase 1 Hmox1 1.45 ± 0.77 4.40 ± 0.67 2.00 ± 0.72 18.81 ± 0.87 
Heat shock protein 27 kDa Hspb8 1.97 ± 1.33 4.00 ± 0.75 2.77 ± 0.82 55.97 ± 0.76 




3.4.2 Validation of microarray analysis via Western blotting 
Western blotting technique which detects protein expression through specificity of binding 
by the individual protein-specific antibody is used to verify microarray data. It is of 
valuable worth if a transcriptional regulation equates to translational regulation as not all 
transcriptional regulation is reflected in the translational expression of the proteins. 
Nevetheless, majority of protein regulation is influenced by the mRNA expression level. 
As shown by the immunoblot analysis of AnxA3 (Figure 3.4.2A) and Serpinh1 (Figure 
3.4.2B), their protein levels were in close correlation to their respective transcriptional 






























Table 3.4.2. Validation of microarray data using Western blotting technique on cultured day 7 mouse primary 
cortical neurons treated with 200 µM NaHS. Data are expressed as fold-change ± SE. 
Gene Title Symbol Microarray Western Blotting (Protein Expression) 
  24 h 24 h 
Annexin A3 AnxA3 4.98 ± 1.00 
 
 
Figure 3.4.2 (A) Increase in protein expression of Annexin A3 
(AnxA3) was observed at 24 h time-point upon 200 µM NaHS 
treatment on mouse primary cortical neurons. This was in 
perfect correlation to a significant AnxA3 transcriptional up-
regulation. 10 µg of proteins was loaded per lane. Data are 











2.23 ± 0.46 
 
Figure 3.4.2 (B) Densitometric analysis revealed a 1.8 fold-
change increase in Hsp47 protein expression at 24 h NaHS post-
treatment. This corresponded to the transciptional up-regulation 
of Hsp47 which peaked significantly only at 24 h. 10 µg of 









 3.4.3 Validation of microarray analysis via proteomics approach 
 
Proteomics analysis using 2-DIGE technique with employment of CyDye Fluophors (Figure 
3.4.3A) permits the establishment of global protein expression profile in H2S-mediated 
neuronal apoptosis. 200 µM NaHS neuronal sample collected at 24 h post-treatment was used 
for this analysis. Proteins with expression fold-change beyond ± 2 selected by the DeCyder v 
6.0 software were selected and noted in the pick list. The 2D-gels containing CyDye 
Fluophors-labeled protein samples were stained with silver (Figure 3.4.3B) and spots with 
significant fold-change ± 2 were excised and processed, with subsequent identification of their 
protein identities by MALDI-TOF MS/MS. Three out of a total of 12 identified proteins 
demonstrated a protein regulatory profile similar to their corresponding gene regulatory 
profiles (Table 3.4.3).  All of these three spots with significant protein regulation were related 




Figure 3.4.3 (A) Overlapped image of Cy3 (Green; Control) and Cy5 (Red; Treated) –labelled proteins on a single 2D-





Figure 3.4.3 (B) Demonstration of protein spots with significant fold-change difference of beyond ± 2 in NaHS-treated 
neuronal sample on the silver stained 2D-gel. Resolution of this scanned image is unable to reach a true representation of 
the original gel, as such, faint spots on the gel were unable to be captured in this image.
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Table 3.4.3. Proteins significantly regulated with fold change beyond ± 2 during H2S-mediated neuronal excitotoxic death and 
whose translational regulation matched that of the transcriptional regulation. Data are expressed as fold-change ± SE. 
Gene Title Symbol Microarray 2-DIGE Proteomics (Protein Expression) 
   Spot 
No. 
Protein identified by 






terminal hydrolase L1 
















-1.66 ± 0.11 
-2.15 ± 0.14 
-1.55 ± 0.11 












Ube2n -2.48 ± 0.08 2080 
Ubiquitin-conjugating 




































3.4.4 Validation of microarray analysis via lysosomal membrane stability assessment 
 
As microarray analysis demonstrated gene up-regulation of lysososmal enzymes, cathepsin 
B, C and Z prominently at 24 h (Table 3.3.2 and 3.4.4), we employed the lysosomotropic 
fluorescence probe, acridine orange (AO) to examine changes of lysosomal membrane 
stability. Figure 3.4.4A shows untreated mature mouse primary cortical neurons loaded 
with the lysosomal specific dye, acridine orange depicting extensive cytosolic green 
fluorescence and lysosomal red fluorescence. However, upon addition of 200 µM NaHS at 
24 h post-treatment, red (lysosomal) fluorescence was lost and a sharp increase in cytosolic 
green fluorescence was observed, indicative of AO redistribution and lysosomal membrane 
rupture (Figure 3.4.4A). Furthermore, treatment of cells with the lysosomal membrane 
stabilizer guanabenz or NMDA receptor antagonist MK801 prior to the addition of NaHS 
prevented AO redistribution (Figure 3.4.4B).  
 
Table 3.4.4 Validation of microarray data using AO re-distribution technique to assess lysosomal membrane 
stablization on cultured day 7 mouse primary cortical neurons treated with 200 µM NaHS. Data are expressed 
as fold-change ± SE. 
 
Gene Title Symbol Microarray 
  5 h 15 h 24 h 
Cathepsin Z (Ctsz) Ctsz 1.13 ± 0.30 1.35 ± 0.45 1.98 ± 0.62 
Cathepsin B (Ctsb) Ctsb 1.08 ± 0.20 1.27 ± 0.23 1.58 ± 0.34 















































































































































































































































































































































































































































































































































































































































This study revealed that H2S induces a concentration-dependent apoptosis-necrotic 
continuum of neuronal cell death (Figure 3.1.1 and 3.1.2) through the activation of 
glutamate receptors notably NMDA and kainate receptors (Figure 3.2.3), with a 
potentiation of neurotoxicity upon co-application with L-glutamate (Figure 3.2.1). Our 
research data are in stark contrast to that of Kimura and Kimura, 2004 which demonstrated 
a neuroprotective effect offered by H2S upon induction of neuronal death in the presences 
high doses of L-glutamate. The possible explanation for this discrepancy lies in the level of 
expression and functionality of the GluRs on the neuron cell surface. It is speculated that 
the the cells used by the former were immature mouse cortical neurons which showed 
absence of GluRs. Indeed, in our cultured neurons system, full expression of functional 
GluRs was only attained from day 5 cultures (Figure 3.2.2). 
 
4.1 Elucidation of essentiality of various cell death-related pathways in H2S-mediated 
apoptosis through microarray analysis 
Since the discovery of H2S inducing neuronal death is precedental, a screening of the 
global gene profile using microarray technique would be utmost useful in providing clues, 
and thus allow piecing of various parts of the puzzle to elucidate the mechanism of 
signaling in H2S-mediated neuronal death. Due to its abundant endogenous expression in 
the brain, and its involvement in both physiological and path-physiological conditions such 
as stroke and AD, it would thus be worthwhile to understand the dual roles that H2S 
exhibits in both situations respectively. Although the physiological role of H2S as a 
neuromodulator has been extensively studied, the part it plays under patho-physiological 
condition in the brain is still lacking. Furthermore, with the perturbed synthesis of H2S 
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implicated in various neurodegenerative diseases, whether H2S exists as a friend or foe to 
the neurons survival still requires further confirmation. Microarray data provides insights 
on the essentiality of various cellular processes in H2S-mediated neuronal death as well as 
the sequential occurrence of these events. 
 
4.1.1 Role of the apoptotic mechanism in cell death and its relevance in H2S-mediated 
neuronal death 
Apoptosis, otherwise known as programmed cell death (PCD), is a regulated mechanistic 
mode of cell death which is characterized by morphological changes such as cellular 
shrinkage, chromatin condensation, membrane blebbing with the subsequent formation of 
apoptotic bodies and DNA laddering. It is a genetically controlled form of cell death that is 
central to the development and homeostasis of multicellular organisms. With increasingly 
compelling evidence demonstrating diversity in cell death phenotypes and their associated 
molecular mechanisms, the classic definition of apoptosis and its characteristics are no 
longer ubiquitous. Up to date, apoptosis has been shown to be able to occur in complete 
absence and independent of caspase activation (Xiang et al., 1996). Alternative models of 
PCD such as paraptosis, autophagy, mitotic catastrophe and caspase-independent pathways 
are proposed.  
 
Neuronal apoptosis has been implicated in the pathogenesis of numerous 
neurodegenerative disorders such as AD and PD, thus the role it plays is crucial to ensure 
cell demise. A comparison of the regulation of apoptosis-related genes between H2S-and 
NMDA-mediated neuronal death models revealed a smilar up-regulation trend, with the 
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latter demonstrating an earlier elevation of gene expression at 5 h as opposed to the 15 h in 
the former. The earlier activation of apoptosis in NMDA-treated neurons could be 
explained by the affinity of the NMDA receptors for its specific pharmacological activator, 
NMDA, and thus the direct induction of the downstream signaling cascade. On the other 
hand, though H2S has been demonstrated to trigger the NMDA receptor activation, it is not 
known yet how this interaction is brought about. It could be a direct interaction between 
ligand (H2S) and receptor (NMDA receptors) though the binding affinity may not be 
exceptionally high, or there is the presence of an intermediate molecule to trigger the 
receptor activation. As such, both of these speculations could account for the later 
activation of the apoptotic genes. 
 
In addition, genes which encode proteins involved in the mitochondrial-dependent caspase-
3-mediated cell death signaling pathway demonstrated significant down-regulation in both 
treatment models. This further substantiated the lack of caspase-3 activation, as 
demonstrated by immunoblot analysis in Figure 4.5. 
 
As demonstrated by microarray analysis (Table 3.3.1) and real-time PCR (Table 3.4.1), 
transcriptional expression of Angptl4 was up-regulated in NaHS treatment. This is the first 
time that Angptl4 mRNA expression has been demonstrated to be highly up-regulated in 
mouse primary cortical neurons treated with NaHS. The significance of up-regulation 
remains to be elucidated as the relevance of role of Angptl4 in the CNS still lacks 
substantial findings. However, speculations based on existing discoveries on other cell 
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types, it can be inferred that the elevated Angptl4 gene expression is attributed to its anti-
proliferative effect imposed on neurons committed to cell death. 
 
Angiopoietin-like (Angptl) proteins, belongs to a family of proteins structurally similar to 
the angiogenic regulating factors angiopoietins through their identical N-terminal coiled-
coil domain and a C-terminal fibrinogen-like domain. However, in contrast to 
angiopoietins, Angptls do not bind to either the angiopoietin receptor Tie2 or the related 
protein Tie1 and remain orphan ligands.  
 
Angptl4, a secreted glycoprotein implicated in negative regulation of metastasis and 
angiogenesis, is a downstream target of the peroxisome proliferator-activated receptor α 
(PPARα) and γ (PPARγ) (Xin et al., 1999; Yoon et al., 2000). In the endothelial cells, 
Angptl4 is able to suppress proliferation, migration and tubule formation and decreases 
vascular leakage. It has also been demonstrated to directly regulate lipid, glucose, and 
energy metabolism independently of angiogenic effects. Bäckhed et al., 2004 reported that 
expression of genes encoding the peroxisome proliferator-activated receptor coactivator 
(Pgc-1α) and enzymes involved in fatty acid oxidation was reduced in Angptl4 knockout 
mice, in addition to increased lipoprotein lipase activity and induced triglyceride deposition 
in mouse adipocytes. A recent study by Wang et al., 2007 suggested Angptl4 to regulate 
mitochondrial function through activity of the mitochondrial respiratory chain complexes II 




4.1.2 Role of the ER stress in cell death and its relevance in H2S-mediated neuronal 
death 
 
The ER is a crucial homeostatic regulator of cellular stress through modulating protein 
synthesis and metabolism (Travers et al., 2000). Extensive ER damage can trigger 
apoptosis via the production of unfolded proteins or the release of Ca
2+
 into the cytoplasm 
(Breckenridge et al., 2003). ER stress can activate caspase-12 and trigger apoptosis or 
cause mitochondrial membrane permeabilization which results in either classical apoptosis 
or other mitochondrial cell death pathways (Jimbo et al., 2003). In addition, the Ca
2+
 
release from ER can induce calpains, which are normally kept inactive by their endogenous 
inhibitor, calpastatin (Wang, 2000). Excessive calpain activation in vitro can lead to 
degradation of constituent proteins, including cytoskeletal proteins, growth factor 
receptors, and transcription- and cell cycle-related proteins.  
 
Since H2S-mediated neuronal death has been attributed to ionotropic glutamate receptor 
activation, and that NMDA receptors displayed the highest Ca
2+
 permeability upon over-
stimulation, excess influx of Ca
2+
 from the extracellular space in addition to release from 
intracellular stores, ER and lysosomes, might further potentiate the elicitation of apoptosis 
through increase activation of Ca
2+
-dependent proteases calpains and phosphatase 
calcineurin activation. The activated calcineurin in neurons was implicated in the 
dephosphorylation of downstream apoptotic targets, resulting in their activations and 
consequentially excitotoxic neuronal death. The proposed flow of signaling events is highly 
probable with the demonstration of early NMDA receptors activation (Figure 3.2.3), 
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calpain induction at 5 h (Figure 3.2.5) and subsequent destabilization of the lysosomal 
membrane (Figure 3.4.4A). 
 
A “calpain-cathepsin hypothesis” was formulated by Yamashima et al., 1998 on the basis 
of the experimental paradigm of global brain ischemia in primates. Two classes of 
lysosomal proteases appear to be most active in neuronal cell death: aspartyl (cathepsin D) 
and cysteine (cathepsins B, H, L) proteases. The calpain-cathepsin cascade mechanism of 
cell death involves Ca
2+
 mobilization through the uptake of extracellular Ca
2+
 and/or the 




 mobilization can lead to the activation of calpains 
which induces lysosomal rupture, possibly with the aid of reactive oxygen species. The 
released lysosomal proteases, mainly the cathepsins, will then degrade the cell constituent 
proteins, ultimately leading to cell death.  
 
Since calpain activation and 145/150 kDa alpha-fodrin cleavage could also be achieved via 
lysosomal rupture (Posner et al., 1995) with concomitant release of lysosomal proteases 
and that calpain activation has been reported to associate with lysosomal rupture leading to 
the death of post-ischemic CA1 neurons (Yamashima et al., 2003), AO redistribution 
(Figure 3.4.4A) and microarray data (Table 3.4.4) showed prominent lysosomal rupture at 
24 h post-treatment. These observations indicated presence of ER stress, in which 
lysosomal destabilization occurred prior to cathepsins gene up-regulation. Further 
substantiation through application of specific NMDA receptor antagonist, MK801 
prevented H2S induction of neuronal apoptosis (Figure 3.2.3) with retention of intact 
lysosomal structures (Figure 3.4.4B), highlighting the crucial roles of NMDA receptors in 
H2S-mediated neuronal death. 
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A cross comparison of microarray data of H2S- and NMDA-mediated neuronal death 
showed an increase in cathepsin B, C and Z transcriptional up-regulation with the former 
occurring at 24 h of H2S-mediated neuronal apoptosis and the latter at 5 h (Table 3.3.2), 
indication of an earlier induction of ER stress in NMDA treatment which led to earlier 
lysosomal rupture. 
 
4.1.2.1 CCAAT/enhancer binding protein (C/EBP) 
C/EBPs, a transcription factor family of at least eight isoforms encoded by six genes, are 
also potentially implicated in survival and differentiation processes (Sterneck and Johnson, 
1998). C/EBPs possess a transactivating domain, a DNA binding region, and a leucine 
zipper and function as dimers (Olive et al., 1996). Regulation of C/EBPs is complex and 
can be attained transcriptionally, posttranslationally, and by formation of hetero- as well as 
homodimers (Niehof et al., 2001). C/EBPs can heterodimerize to form transcriptional 
enhancers or repressors potentially altering DNA binding specificities or transactivating 
capabilities (Descombes and Schibler, 1991; Xiong et al., 2001). 
 
As demonstrated in Table 3.3.2, the gene encoding the C/EBP beta (Cebpb) was 
significantly up-regulated at 5 h for NMDA treatment and at 24 h for NaHS treatment. 
C/EBP beta is regulated by Ca
2+
/CaM-dependent protein kinase-IV (CaMKIV; Yukawa et 
al., 1998), in addition to PI3K and Akt (Guo et al., 2001; Piwien-Pilipuk et al., 2001), both 
of which are vital for IGF-1/L channel potentiation-induced survival (Blair and Marshall 
1997; Blair et al., 1999). The role of C/EBP beta on cell survival and death remains 
controversial. C/EBP beta has been demonstrated to assume a pro-proliferative role in non-
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neural cells (Buck et al., 2001; Zhu et al., 2002), and in PC12 cell line, its activity was 
elevated upon cell stimulation by nerve growth factor (Sterneck and Johnson, 1998). On 
the other hand, in Neuro-2A cell line and cerebellar neurons, C/EBP beta has been reported 
to be detrimental to cell survival (Cortes-Canteli et al., 2002; Marshall et al., 2003). C/EBP 
beta has been proposed to exert its pro-apoptotic effect through its rapid increase in 




4.1.2.2 DNA damage-inducible transcript 3 (Ddit3) 
 
Ddit3, also known as C/EBP-homologous protein (CHOP), is a small nuclear protein 
transcription factor of the C/EBP family that is normally undetectable but expressed at high 
levels in cells exposed to conditions that perturbed protein folding in the ER and induces 
ER stress response (Wang et al, 1996). In the event of oxidative stress, ER is highly 
susceptible to ROS damage which would consequentially cause apoptosis. The expression 
of Ddit3/CHOP in stressed cells is linked to the development of programmed cell death 
(Zinszner et al, 1998). A recent study by Hayashi et al., 2005 demonstrated an increase in 
Atf4 and Ddit3 protein expression in the hippocampal CA1 neurons resulting in apoptosis 
in wild type mice subjected to ischemic condition. However, in transgenic mice 
overexpressing human copper/zinc superoxide dismutase, negligible activation of Atf4 and 
Ddit3 was observed with attenuation of neuronal death upon induction of cerebral ischemia 
(Hayashi et al., 2005). The increase in Ddit3/CHOP protein expression is believed to lead 
to the suppression of the Bcl-2 expression in the cells, which make them more susceptible 
to apoptosis (McCullough et al., 2001). 
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Real-time PCR data performed on NaHS-treated neuronal samples demonstrated a 
transcriptional up-regulation of Ddit3 (Table 3.4.1) matching that of microarray analysis 
(Table 3.3.2). The rise in Ddit3 gene expression at 24 h indicated that ER stress was 
experienced at the late phase of H2S-mediated neuronal death. In contrast, the rise in Cebpb 
gene expression was not met with a corresponding transcriptional increase in Ddit3. Taking 
into consideration of the early significant gene elevation of cathepsins, this possibly 
implied that ER stress was an early upstream event of NMDA-mediated neuronal death. 
 
4.1.3 Role of the calcium homeostasis and binding in cell death and its relevance in H2S-
mediated neuronal death 
Calcium influx arising from activation of different calcium channel subtypes situated at 
various cellular locations has been found to induce two antagonizing outcomes: survival 
and proliferation, or cell death. The stark difference in cell fate is proposed to be due to the 
differential subcellular localizations of calcium-dependent proteins, in which upon Ca
2+
 
stimulation elicits different signaling responses.  
 
Abnormal calcium homeostasis arising from ER stress and increase ROS production can 
manifest as activation of intracellular signaling cascades which can lead to apoptosis 
through the activation of calcium-activated calpains (Crocker et al., 2003; Nakagawa and 
Yuan, 2000). In both H2S- and NMDA-treated neurons, consistent up-regulatory trend was 
observed in all calcium homeostatic-related genes with the former showing individual gene 
up-regulation at different time-points while the latter demonstrating majority of gene up-
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regulation occurring at 15 h, all a clear indication of presence of ER stress in both modes of 
cell death (Table 3.3.3).  
 
Microarray data revealed an early gene immense up-regulation of AnxA3 at 5 h, with 
consistent further elevation at 15 h and 24 h respectively in H2S-mediated neuronal 
apoptosis (Table 3.3.3). Corresponding to this increase in gene expression, a significant 
increase in AnxA3 protein expression also entailed (Figure 3.4.2A). On the other hand, in 
NMDA-mediated neuronal death, similar significant up-regulation of AnxA3 was also 
observed at 15 h. 
 
Annexin A3 (AnxA3), belonging to the annexin superfamily, possesses the basic structural 
properties: it has the four annexin domains and interacts with the anionic phospholipid 
membrane in a Ca
2+
-dependent manner through its convex face. The unique NH2-terminal 
region of AnxA3, situated at the concave face of the protein, is 20 amino acid-residues in 
length, and has been found to be involved in modulation of membrane binding as well as of 
ion permeabilization. For instance, the W5A mutation was reported to reduce the affinity 
between AnxA3 and membranes in vitro (Gerke and Moss, 2002; Hofmann et al., 2000; 
Sopkova et al., 2002). 
 
Up-regulation of AnxA3, when a neuron has committed to apoptosis, is counter-intuitive 
and puzzling. AnxA3 seems to be involved in numerous diverse functions, such as cellular 
glucuronic acid-induced heat shock stress response (Kim et al., 2004), contributing 
possibly to the cancerous nature of tumor cells, as it was deemed a good marker of cardiac 
myxoma (Skamrov et al., 2004), and is up-regulated in pancreatic ductal adenocarcinoma 
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(Shekouh et al., 2003), but not in the apoptotic process. Clues to the possible function of 
AnxA3 based on cell types have been limited to the context of microglial cells (Konishi et 
al., 2006), phagocytic cells (Majeed et al., 1998), umbilical vein epithelial cells (Park et al., 
2005), and hepatocytes (Niimi et al., 2005). There are no published reports that fully 
explain the role of AnxA3 during neuronal apoptosis.  
 
In our neuronal model system, AnxA3 is believed to play a crucial in the initial stage of 
trigger of H2S-mediated neuronal death probably through its role in ion permeabilization, 
causing perturbed ion homeostasis resulting in activation of various ion-activated pro-
apoptotic proteins. 
 
4.1.4 Role of the pro-survival pathway in cell death and its relevance in H2S-mediated 
neuronal death 
Pro-survival mechanisms such as the MAPK, PI3K-Akt and GSK3b pathways were in 
placed in the cells to suppress the activation of cell death signaling cascade. Upon the 
induction of death signals which overwhelms the cell survival machinery, the promotion of 
cell survival is suppressed, and the cells are commited to demise. As demonstrated by 
Table 3.3.4, genes encoding proteins involved in the pro-survival pathways including 
Mapk1, Vegfa, Gsk3b and Ube2n were significantly suppressed in both NaHS and NMDA 
treatment at 24 h and 15 h respectively. Nevertheless, gene expression of Igf2 and Bdgf 
showed significant elevation at 15 h in an attempt to reverse neuronal death in both models. 
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Microarray revealed a consistent up-regulation of Igf2 in both H2S- and NMDA-mediated 
neuronal deaths, while other pro-survival genes demonstrated down-regulation (Table 
3.3.4). 
 
Insulin-growth factors (Igfs) are divided into Igf1 and Igf2. Igf1, mainly secreted by the 
liver, is importance in the maintenance of physiological homeostasis and plays an 
importance role in promotion of cell proliferation and suppression of cell death. Igf2, on 
the other hand, is secreted by the brain, kidneys, muscles and pancreas, and assumes a 
more vital role in early fetal development for regulation of cellular proliferation, 
differentiation and development. Nevertheless, Igf2 is still required for the proper 
functioning of vital organs such as brain, kidneys and liver. 
 
Igf1 promotes neuronal survival through indirect activation of L-type channel-mediated 
calcium influx (Peterson et al., 1999), which leads to activation and nuclear translocation 
of calmodulin via MAPK pathway (Dolmetsch et al., 2001) and increase in nuclear Ca
2+
 
levels that, in turn, stimulate CaMKIV to phosphorylate CREB and MEF2, survival-
promoting transcription factors (Deisseroth et al., 1998). Similarly, Igf2 is also involved in 
the activation of the pro-proliferative PI3K-Akt and MAPK pathways (Kim et al., 2008).  
 
4.1.5 Role of the mitotic cell cycle regulation in cell death and its relevance in H2S-
mediated neuronal death 
Cell cycle re-activation is a vital component of DNA damage response of postmitotic 
neurons that can result in apoptosis (Kruman et al., 2004). This is substantiated by the 
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results of studies in vitro (Smith et al., 2000) and in vivo (Yang et al., 2001) that terminally 
differentiated neurons destined for cell death are able to replicate DNA. Recently, Iwata et 
al., 2004 showed that cell cycle re-entry caused by increase in cyclin D1 gene expression, 
resulted in cell death. p53 was shown to be activated by poly(ADP-ribose) polymerase-1 
(PARP-1) in the event of DNA damage to stop cell replication and activate DNA repair 
(Mandir, 2002). Re-activation of cell cycle may present a mean of the cell to reverse the 
cell death fate.  
 
Cell cycle re-entry requires only cyclin D1-related molecules due to cyclin D1 function to 
detect the cell readiness for DNA replication (Sherr, 1995). Its mRNA level peaks in G1 
phase and decreases before the S phase of cell cycle in normal cell (Iwata et al., 2004). 
Cyclin D forms complexes with cdk-4 and cdk-6 to hyper-phosphorylate retinoblastoma 
(RB) protein allowing the activation of E2F to initiate the entry into S-phase 
 
p53 serves as a ‘care-taker’ that maintains the integrity of the cell genome. Upregulation of 
phospho-p53 may be attributed to, either significant DNA damage that triggers DNA repair 
or cell death respectively, or unregulated cell cycle entry. p21 and Gadd45 are 
transcriptionally activated by phospho-p53 to induce cell cycle arrest at G1 phase. It is 
important to note that the cells used in this study were neurons which were post-mitotic and 
fully-differentiated cells, meaning that cell cycle re-entry should not occur. 
 
Since there was significant gene down-regulation of Ccnd1 and E2f1 at 24 h (Table 3.3.5), 
this suggested that there was no activation of cell cycle re-entry in our model of H2S-
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mediated neurotoxicity. Transciptional up-regulation of p53 was most likely to be due to its 
activation by PARP-1, resulting in activation of DNA repair. Down-regulation of cell cycle 
genes was significant at 15 h in NMDA-mediated neuronal death, earlier than that of H2S-
induced neuronal apoptosis. 
 
4.1.5.1 Growth arrest and DNA-damage-inducible 45 gamma (Gadd45) 
 
p53 pathway is crucial in the maintenance of the integrity of the cell genome. Protein 
upregulation of phospho-p53 can be triggered by either significant DNA damage causing 
activation DNA repair or cell death respectively, or a cellular response  to re-enter cell 
cycle for proliferation and survival and to evade cell death, or both causes are involved 
(Chen et al., 2005). In the event of DNA damage, PARP-1 induces p53 activation to 
prevent cell replication with damaged DNA and activating DNA repair (Mandir et al., 
2002). As demonstrated by microarray analysis in Table 3.3.5, a gene up-regulation of p53, 
also known as Trp53, was observed, in addition to an increase transcriptional expression of 
its inducible protein (Trp53inp1). 
 
Gadd45, a p53-dependent transcriptional target gene, is up-regulated upon p53 induction, 
which in turn resulted in increase protein expression. Gadd45 has been implicated in 
cellular stress responses through execution of cell cycle arrest, DNA repair, cell survival 
and senescence, or apoptosis. Gadd45 protein functions through physical interaction and 
binding with cellular proteins implicated in cell cycle regulation and the response of cells 




Coupled with the increase in gene expression of p53, a transcriptional up-regulation of 
Gadd45g was also observed through microarray analysis H2S-induced neuronal apoptosis 
(Table 3.3.5). Validation of Gadd45 gene expression using real-time PCR (Table 3.4.1) 
confirmed the up-regulation of Gadd45g at 15 h and 24 h time-points. An early 
transcriptional up-regulation of Gadd45g at 5 h was observed in NMDA treatment. 
 
4.1.5.2 Ubiquitin-conjugating enzyme E2N (Ube2n) 
Ubiquitin-conjugating enzymes E2 (Ube), all of which have a core catalytic domain 
(containing the active site cysteine), and some of which have short N- and C-terminal 
amino acid extensions, have over 30 different isoforms in human and are broadly classified 
into four classes. The ubiquitin-activatin enzyme E1 mediates an ATP-dependent transfer 
of a thioester-linked ubiquitin molecule to a cysteine residue on the E2 enzyme. The E2 
enzyme then either transfers the ubiquitin moiety directly to a substrate, or to an E3 ligase, 
which can also ubiquitinylate a substrate.  
 
Heterodimers composing of Ube2n and its partner ubiquitin-conjugating enzyme E2 variant 
(Ube2v1 or Ube2v2), catalyze the synthesis of non-canonical poly-ubiquitin chains that are 
linked through lysine-63 which does not lead to protein degradation by the proteasome. 
This is due to a lack of the conserved cysteine residue that is critical for the catalytic 
activity of Ube2s, though Ube2v subfamily has sequence similar to other ubiquitin-
conjugating enzymes. Instead Ube2v subfamily proteins localized in the nucleus and are 
involved in the mediation of transcriptional activation of pro-proliferative cell cycle genes 
through heterodimer formation with Ube2n. It is implicated in the regulation of progress 
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through the cell cycle and differentiation. It is also crucial in triggering activation of DNA 
repair pathway upon DNA damage and cell survival. 
 
A transcriptional down-regulation of Ube2n (Table 3.3.5) leading to a reduced Ube2n 
protein expression (Table 3.4.3) at 24 h post-treatment with NaHS demonstrated that the 
neurons were undergoing irreversible death with no cell cycle re-entry to reverse the 
inevitable fate. 
 
4.1.6 Role of Hsps and chaperones in cell death and its relevance in H2S-mediated 
neuronal death 
Hsps and molecular chaperones are crucial in the facilitation of the refolding of misfolded 
proteins to avoid their aggregation and accumulation in the cell (Meriin and Sherman, 
2005). They cooperate with the UPS to prevent intracellular buildup of aberrant toxic 
proteins, and regulate the degradation of excess cytoplasmic proteins. Hsps confer cellular 
protection mainly through two mechanisms: firstly, Hsps act as molecular chaperones to 
ensure correct formation and maintenance of native conformation of cytosolic proteins and 
stabilization of actin filaments; secondly, suppression of the pro-apoptotic member of the 
Bcl-2 family, Bid, by Hsp70 (Hspa8) and Hsp27 (Hspb8) prevents cytochrome c release 
(extensively reviewed in Franklin et al., 2005).  
 
In H2S-induced neuronal apoptosis, substantial up-regulation of Hsps and chaperones 
generally demonstrated an up-regulation at 15 h, much later than the occurrence of gene 
expression elevation seen in NMDA-induced neuronal death at 5 h (Table 3.3.6).  
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4.1.6.1 Sulfiredoxin 1 (Srxn1 / Npn3) 
Sulfiredoxin 1 (Srxn1), an ATP-dependent enzyme, is involved in the catalysis of reduction 
of sulfinic peroxiredoxin (Prdx) enzymes. To date, Srxn1 functions solely to reverse the 
sulfinic modification of 2-Cys Prx enzymes. Specificity of Srxn1 interaction with 2-Cys 
Prdx enzymes is conferred by several critical surface-exposed residues on the Prxs, and this 
association results in the transfer the gamma-phosphate of ATP to their sulfinic moiety, 
using its conserved cysteine as the phosphate carrier. The consequence is the reduction of 
the sulfinic phosphoryl ester to cysteine with concomitant oxidation of four thiol 
equivalents. 
 
Srxn contributes to increase resistance against oxidative stress through reduction of 
cysteine-sulfinic acid when exposed to oxidized peroxidoxins (Prdx) 1 - 4. This was 
demonstrated by the transcriptional up-regulation of Srxn1 from 15 h to 24 h in H2S-
mediated neuronal death (Table 3.3.6) which might be induced in relation to the incidence 
of ER stress at 24 h. This gene up-regulation was translated to an increase in protein 
expression (Figure 3.4.2A). On the other hand, NMDA-treated neurons demonstrated an 
early gene up-regulation from 5 h (Table 3.3.6), an early anti-oxidative response which 
coincided with the time of occurrence (5 h) of ER stress (Table 3.3.2). This increase in 
gene expression when translated to elevated protein expression promotes increased 
reduction of sulfinic 2-Cys Prdx enzymes, thus enhancing peroxidase activity of 2-Cys 
Prdx to degrade ROS, an anti-oxidant response. 
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Prdx, a family of bifunctional proteins that display peroxidase and chaperone activities, 
contains a conserved cysteine residue that undergoes a redox change between thiol and 
disulfide states. Intrinsic susceptibility to reversible hyperoxidation to cysteine sulfinic acid 
during Prdx catalysis is particularly prominent in a subfamily called 2-Cys Prdx. Cysteine 
hyperoxidation of Prdx was shown to result in loss of peroxidase activity and a 
concomitant gain of chaperone activity (extensively reviewed in Rhee et al., 2007). 
 
Down-regulation of Prdx2 was observed and might occur in response to increase Srxn1 
expression. Another explanation was that with increased ROS production due to ER stress, 
Prdx experienced cysteine hyperoxidation with a loss of peroxidase activity, as such a 
decrease in Prdx protein levels would in turn decrease oxidized protein accumulation.  
Since Srnx1 does not act on peroxiredoxin 5 and 6, no suppression of its gene expression 
(Prdx6) was observed (Table 3.3.6). Similarly, glutathione peroxidase 1, is a strong 
antioxidant enzyme which catalyzes the reduction of lipid-hydroperoxides and hydrogen 
peroxides to harmless products through oxidation of its cofactor glutathione to glutathione 
disulphide. Its activity is useful as a univariate molecular marker for risk of cardiovascular 
events where an elevation of red cell glutathione peroxidase 1 equates to a better prognosis.  
 
4.1.6.2 Metallothioneins  
In addition to the transport and compartmentalization of metal ions, copper chaperone for 
superoxide dismutase (Ccs) and metallothionein 3 (Mt3) are able to offer cellular protection 
against oxidative stress. The metallothioneins are involved in the homeostatic maintenance 
of cellular redox status and a reduction would result in increase susceptibility to oxidative 
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stress and metal-induced neurotoxicity (Ashner et al., 1997). Thus in an attempt to combat 
the oxidative stress experienced in H2S-mediated neuronal death, a transcriptional up-
regulation of Ccs and Mt3 genes was observed (Table 3.3.6). 
  
4.1.6.3 Heme oxygenase 1 (Hmox1) 
 
Heme oxygenase (Hmox), which exists in two major forms, Hmox1 (inducible form) and 
Hmox2 (constitutive form), is an anti-inflammatory cum cytoprotective enzyme molecule 
(Wu and Wang, 2005). Hmox is involved in the degradation of free oxidative heme 
producing by–products such as bilirubin/biliverdin, CO and free iron (Morse and Choi, 
2002). Hmox1 is noted to be involved in tissue and cellular defense against oxidative stress 
and one of the multiple mechanisms in which it executes its cytoprotective effect is through 
its induction by CO which results in down-regulation of inducible NO synthase (iNOS; 
Otterbein et al., 2003; Srisook and Cha, 2005). As the inflammatory state progresses, 
Hmox1 activity is markedly increased with the highest expression occurring during 
resolution of the inflammation (Willoughby et al., 2000). iNOS, among the three isoforms 
of NOS, is responsible for the production of high amounts of NO during disease, injury, 
and inflammation (Chung et al., 2001). 
 
Recent study by Jin et al., 2006 reported that treatment of NaHS on cultured airway smooth 
muscle cells (ASMC) resulted in the inhibition of Hmox1 expression in a dose-dependent 
manner through H2S regulation of CO production. Similarly, experiments conducted by Oh 
et al., 2006 demonstrated that H2S induced inhibition of NO production and iNOS 
expression through activation of the Hmox1 pathway by ERK in RAW264.7 macrophages 
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stimulated with LPS. It further demonstrated the inhibition of LPS-mediated NF-κB 
through Hmox1/CO-dependent pathway (Oh et al., 2006). 
 
Consistent with these previous findings, microarray analysis on NaHS-treated neurons also 
demonstrated a substantial transcriptional up-regulation of Hmox1, which was further 
validated by microarray (Table 3.3.6) and real-time PCR (Table 3.4.1) analyses at the late 
phase (24 h) of neuronal death. Hmox1 gene expression was substantially up-regulated 
from 5 h NMDA post-treatment, a smilar regulation trend as Srxn1, indicating an early 
incidence of ER stress in NMDA-mediated neuronal death (Table 3.3.6). 
 
4.1.6.4 Heat shock protein 27 (Hsp27 / Hspb8) 
 
Hsp27, a member of the small heat shock protein (sHSP) family, is activated upon stress 
induction and offers a cytoprotective response against oxidative stress, hypertonic stress, 
heat shock, mitochondrial damage and other forms of cellular injury in multiple cell types 
such as cardiomyctes (Brar et al., 1999; Martin et al., 1997), endothelial cells (Ferns et al., 
2006) and neurons (Akbar et al., 2003; Benn et al., 2002). A reduction in endogenous 
Hsp27 would translate to an increase in susceptibility to apoptosis (Paul et al., 2002). 
Cellular protection by Hsp27 is also demonstrated in models of cerebral (Akbar et al., 
2003) and myocardial ischemia (Hollander et al., 2004) where apoptosis commonly led to 
organ failure (Ueda et al., 2000). In cancer studies, Hsp27 is suggested to provide chemo-
resistance to tumor cells (Oesterreich et al., 1993; Garrido et al., 1997). 
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Hsp27 has been suggested to offer cellular protection by exerting its functions upstream 
and downstream of mitochondrial injury. Prior to mitochondrial damage, Hsp27 inhibits 
cytochrome c release upon pro-apoptotic induction (Concannon et al., 2001; Paul et al., 
2002). Downstream of mitochondrial injury, Hsp27 protects against apoptosis through 
inhibition of caspase-3 and -9 and reduction of apoptosome formation (Bruey et al., 2000; 
Garrido et al., 1999). Hsp27, with the absence of intrinsic ATPase activity unlike Hsp70, 
modulates the activity of its binding partner by deoligomerization (Giese and Vierling, 
2002). 
 
Numerous studies suggested a close association between Hsp27 and Akt, a potent pro-
proliferative serine/threonine kinase, in which Akt has been implicated in the 
phosphorylation and activation of Hsp27 (Konishi et al., 1997; Suga et al., 2005). A recent 
study by Havasi et al., 2008 reported that Hsp27 potentiates PI3K activity, thus enhancing 
downstream Akt interaction and phosphorylation of Bax. The inactivated Bax is unable to 
oligomerize and translocate to the mitochondria.  
 
In H2S-mediated excitotoxic neuronal death, Hsp27 demonstrated a significant up-
regulation of gene expression at 15 h (Table 3.3.6), reaching its peak level at 24 h in NaHS 
treatment (confirmed by real-time PCR; Table 3.4.1). In contrast, Hsp27 transcriptional up-






4.1.6.5 Heat shock protein 47 (Hsp47 / Serpinh1) 
Hsp47, a 47 kDa collagen-binding molecular chaperone, is a member the serine protease 
inhibitor (serpin) superfamily possessing a serpin signature sequence (Whisstock et al., 
1998). It is known as a molecular chaperone that is specifically involved in the Hsp47, is 
expressed in the endoplasmic reticulum of cells producing type I collagen, and is actively 
involved in type I collagen biosynthesis (Natsume et al., 1994). It is crucial in ensuring 
proper processing and quality control of collagen molecules (Taguchi and Razzaque, 
2007). 
 
Gene up-regulation of Hsp47 was only significant at the 24 h time-point of NaHS treatment 
(Table. 3.3.6). As a result of this transcriptional up-regulation, an increase in Hsp47 protein 
expression was also observed (Figure 3.4.2B). The late phase up-regulation of Hsp47 might 
imply a cellular response to reduce aberrant collagen accumulation as a consequence of 
reduced UPS efficiency arose from oxidative stress. UPS dysfunction was also prominent 
at the late phase (24 h) of H2S-induced neuronal death (Table. 3.3.7) as demonstrated by 
the significant down-regulation of UPS genes. 
 
On the other hand, significant gene up-regulation of Hsp47 in NMDA-mediated neuronal 
death took place at 5 h post-treatment, a further support of the cellular experience of ER 





4.1.7 Role of the Ubiquitin-Proteasome System (UPS) in cell death and its relevance in 
H2S-mediated neuronal death 
 
The UPS is a multi-step eukaryotic protein quality control system, where aberrant proteins 
are molecularly marked with poly-ubiquitins and hence are destined for degradation in the 
proteasome. Fundamentally, linkage of proteins to ubiquitin can elicit distinc downstream 
signaling outcome. Monoubiquitylation relates
 
a sorting signal for membrane proteins to 
the endosome–lysosomal
 
pathway while polyubiquitylated proteins (covalently linked
 
to 
Lys48 of Ub) are targeted to the 26S proteasome for degradation.
 
The three basic groups of 
enzymes engaged in the ubiquitylation
 
processes, namely the E1 (Ub-activating), E2 (Ub-
conjugating)
 
and E3 (Ub ligase) enzymes help to control
 
the sorting and localization of 
individual proteins in a reversible
 
manner. Deubiquitinylating enzymes which comprises of 
ubiquitin carboxyl-terminal hydrolases (Uchs) and ubiquitin-specific proteases (Usps) are 
thiol proteases
 
that hydrolyze the isopeptide bond between the substrate and
 
the C-terminal 
Gly76 of Ub.  
 
The UPS assumes an important role in the degradation of misfolded and unfolded proteins 
in the neurons (Sherman and Goldberg, 2001; Schroder and Kaufman, 2005). Decrease in 
UPS efficiency has been reported in aging (reviewed in Gaczynska et al., 2001) and 
neurodegenerative disorders (Mandel et al., 2005). Mandel et al., 2005 reported a down-
regulation of genes encoding proteasome subunits in the substantia nigra pars compacta of 
Parkinson’s disease brain, indicating a crucial role of the robust transcription of proteasome 
subunits in neuronal survival under stress conditions. 
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In H2S-mediated neuronal apoptosis, significant down-regulation of genes encoding for 
proteins involved in the UPS was most prominent at 24 h, an indication of UPS dysfunction 
being a downstream consequential outcome in this cell death model (Table 3.3.7). This 
gene down-regulation was corresponded to a decrease in protein expression (Table 3.4.3). 
On the other hand, in NMDA-mediated neuronal death, majority of UPS-related genes 
showed no significant fold-change except for a few candidate genes with substantial down-
regulation at 15 h and 24 h (Table 3.3.7). 
 
4.1.7.1. Ubiquitin C-terminal hydrolase L1 (UchL1) 
Ubiquitin C-terminal hydrolase (Uch) L1 and L3, identified in mammals, are small protein 
molecules of 220 amino acids that
 
share more than 40% homology. They are involved 
both in the processing of ubiquitin precursors and of ubiquitinated proteins. This enzyme is 
a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of 
ubiquitin. It also binds to free monoubiquitin and may prevent its degradation in 
lysosomes. The homodimer may have ATP-independent ubiquitin ligase activity.However, 
unlike Uchl3 which is ubiquitously distributed, Uchl1 is expressed exclusively in neurons, 
testis, ovary and placenta (Wilkinson et al., 1989; Wilkinson et al., 1992). Uchl1 is a 
deubiquitinylating enzyme whose mutations have been implicated in PD and gracile axonal 
dystrophy. In the brain, Uchl1 accounts for 1-5 % of total soluble proteins, majority of 
which is found in the neurons. Similar to ubiquitin, Uchl1 is a common constituent
 
of 
cellular aggregates that are indicative of neurodegenerative
 
disease such as Lewy bodies in 
PD (Lowe et al., 1990). Osaka et al., 2003 demonstrated that Uchl1 with a high avidity and 
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affinity for ubiquitins, increases the half-life of monoubiquitin through interaction and co-
localization.  
 
At 24 h NaHS treatment, a decrease in Uchl1 protein expression (Table 3.4.3) was 
observed which complemented to a transcriptional drop in Uchl1 regulation (Table 3.3.7). 
This further implied that a dysfunction of the UPS was observed as a downstream 
consequential effect of H2S-mediated neuronal excitotoxic death. In contrast, no significant 
fold-change in Uchl1 gene expression was observed in NMDA-treated neurons (Table 
3.4.3). 
 
4.1.7.2 Proteasome subunit beta 2 (Psmb2) 
The proteasome is a multicatalytic proteinase complex which is characterized by its ability 
to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral 
or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This 
subunit has a chymotrypsin-like activity.The mammalian 26S proteasome comprises
 
of a 
20S core particle capped by two 19S regulatory complexes.
 
The 20S proteasome is a barrel-
shaped cylinder assembled from four
 
stacked rings of seven subunits each (Groll et al., 
1997). The two external
 
rings are composed of seven alpha subunits (alpha 1-7), and the 
two inner
 





substrates. Proteasome subunit beta 2 (Psmb2) is important in facilitating 
cooperative assembly of the proteasome (De et al., 2003). Standard proteasomes primarily 
involved in protein degradation consist of three ubiquitously expressed catalytic subunits, 
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Since a drastic protein down-regulation of Psmb2 has been observed in 24 h NaHS 
treatment on mouse primary neurons (Table 3.4.3), which might be attributed to Psmb2 
transciptional down-regulation (as supported by the significant reduction in gene 
expression of other members of the proteasome subunit beta family such as Pmsb3, Pmsb5, 
Pmsb7 and Pmsb10; Table 3.3.7), this further substantiates a dysfunction of the UPS, thus 
impeding clearance of aberrant proteins, further aggravating cellular stress resulting in 
neuronal death. Similar gene down-regulation trend of Psmb5, Psmc1 and Psmd5 at 24 h 
had been observed in NMDA-mediated neuronal excitotoxic death, also suggestive of UPS 
inhibition at the late phase of cell death (Table 3.3.7). 
 
4.1.8 Role of the Apoptotic Volume Decrease (AVD) in cell death and its relevance in 
H2S-mediated neuronal death 
Cell shrinkage is a precedent event of apoptosis consistently occurring in all physiologic 
apoptotic models. In the recent years, the term ‘apoptotic volume decrease’ (AVD) is 
employed to denote the decrease in cellular volume in the absence of osmotic imbalance in 
apoptosis resulting in visible morphological cell shrinkage. Cell shrinkage is a ubiquitous 
and fundamental feature of programmed cell death that is independent of the apoptotic 
insults and conserved among species (Chen et al., 2008). Various drug-induced apoptotic 
models to mimic the pathological conditions of neurodegenerative disorders such as AD 
and PD ubiquitously demonstrated the occurrence of cell shrinkage. In a healthy brain, the 
presence of glial cells and blood-brain-barrier allows buffering of any osmotic fluctuations 
in the brain during normal physiological neuronal activity. AVD is more than just a 
morphological cellular observation, but a crucial molecular event that involves the 
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dysregulation of ionic and water homeostasis and cytoskeletal reorganization and 
subsequent progression of apoptosis, e.g. caspase and nuclease activation through 






, together with loss of 
cellular water. 
 







efflux channels was observed in both H2S- and NMDA-induced neuronal death (Table 
3.3.8). Though numerous classical morphological features of cells undergoing apoptosis, 
e.g. cell shrinkage, membrane blebbing, chromatin condensation and DNA fragmentation 
are frequently observed, their occurrences are not universal in all apoptotic cells. Apoptosis 
is a highly regulated process with numerous feedback loops be it positive or negative at 
various stages, ensuring that alternative signaling cascades are present to compensate for 
the deficiency or inefficiency of any one signaling pathways. 
 
4.2 Proposed signaling cascade of H2S-mediated signaling cascade through NMDA 
receptor 
Since the glutamate receptors are a superfamily of various ionotropic and metabotropic 
receptor subtypes, aversion of H2S–mediated neuronal death was achieved upon NMDA 
and kainate receptors (Figure 3.2.3), but on the basis of prominent relationship between 
H2S and NMDA receptors, the focus of interest in this study lies in the association of H2S 
signaling mechanism with NMDA receptor activation.  
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A further in-depth exploration of the mediators of the apoptotic cell death signaling 
cascade revealed an involvement of calpains, a highly conserved family of Ca
2+
-activated 
proteases comprising of two constitutively and ubiquitously expressed calpain isoforms 
namely, µ-calpain (calpain-1) and m-calpain (calpain-2) that are modulated by calpastatin, 
an endogenous inhibitory protein. Calpains have been implicated in the mediation of the 
apoptosis in neurons (Crocker et al., 2003) and cleavage endogenous caspases such as 
caspase-3, -7, -8 and -9 (Chua et al., 2000; McGinnis et al., 1999).  
 
Since H2S-mediated neuronal apoptosis has been attributed to ionotropic NMDA receptor 
activation, and that NMDA receptors displayed the highest Ca
2+
 permeability upon over-
stimulation, excess influx of Ca
2+
 from the extracellular space into the cytosol could elicit 
activation of Ca
2+
-dependent proteases such as calpains and phophatases like calcineurin. 
Indeed, substantial disruption to the calcium homeostasis, binding and transport occurred 
as early as 5 h with particular attention to significant transcriptional up-regulation of 
S100a6 and AnxA3 (Table 3.3.3).  
 
Since AnxA3 has been implicated in modulation of membrane binding as well as of ion 
permeabilization, AnxA3 might promote the elevation of intracellular ion levels 
particularly Ca
2+
, activating pro-apopototic ion-activated proteins. This is crucial as the 
precedent AVD event was absent in H2S-mediated apoptosis, a common feature of 
apoptosis (Table 3.3.8).  
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Furthermore, concomitant activation of calpains was observed at 5 h NaHS post-treatment 
(Figure 3.2.5), a further confirmation of elevated cytosolic Ca
2+
 concentration.  With the 
upstream activation of the cell death initiator calpains, a significant transcriptional of genes 
encoding downstream effector proteins such as Gadd45 and Angptl4, involved in apoptosis 
was observed (Table 3.4.1). 
 
Rise in cytosolic Ca
2+




 release from intracellular 
stores such as ER and lysosomes, thus further potentiate the elicitation of apoptosis through 
increase activation of proteases calpains and phosphatase calcineurin activation. ER and 
lysosomes are organelles that are very vulnerable to damages induced by ROS. Up-
regulation of genes encoding proteins related to ER stress was especially prominent at 24 h 
of H2S-mediated neuronal apoptosis (Table 3.3.2). Gene up-regulation of Ddit3 (Table 
3.4.1), with an eventual increase in its protein expression, was induced upon ER stress in 
the event of perturbed protein misfolding in the ER or oxidative stress. As such, Ddit3, a 
nuclear transcription factor would be activated to increase the gene expression of more pro-
apoptotic proteins. In addition, elevated gene expression of cathepsins was also observed at 
the late phase (24 h) of H2S-mediated neuronal apoptosis (Table 3.3.2). This is highly 
suggestive of lysosomal membrane destabilization, a phenomenon also observed in AD 
(Nixon et al., 2000). The likely occurrence of lysosomal rupture is further supported by AO 
re-distribution analysis which demonstrated ruptures of intracellular organelles such as 
lysosomes and endosomes (Figure 3.4.4A).  
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Calpain activation has been reported to associate with lysosomal rupture leading to the 
death of post-ischemic CA1 neurons (Yamashima et al., 2003). Our study also 
demonstrated consistent findings of lysosomal rupture occurring after calpain activation 
upon neuronal treatment with 200 µM NaHS treatment. In view of the involvement of 
lysosomal rupture with concomitant cathepsin release, Nixon et al., 2006 proposed the 
occurrence of an autophagic event induced by H2S which recruits apoptosis coupled with 
calpain activation to ensure cellular demise 
 
Trancriptional up-regulation of Hsps and chaperones in response to oxidative stress 
occurred at 15 h NaHS-post-treatment, coinciding with that of apoptosis (Table 3.3.6). This 
is probably an attempt by the neurons primarily to suppress pro-apoptotic member of the 
Bcl-2 family, Bid, by Hsp70 (Hspa8) and Hsp27 (Hspb8) prevents cytochrome c release. 
Secondary function of HSPs as molecular chaperones to facilitate correct formation and 
maintenance of native conformation of cytosolic proteins and stabilization of actin 
filaments helps to alleviate oxidative stress (extensively reviewed in Franklin et al., 2005).  
 
Efficiency of UPS is particularly susceptible to compromise by oxidative stress. 
Accumulation of aberrant proteins as a result of UPS dysfunction is commonly accounted 
for involvement in the pathogenesis of many neurodegenerative diseases such as PD and 
AD. AD is characterized by the loss of neurons involved in learning and memory, with 
hallmark lesions of extracellular amyloid plaques and intraneuronal neurofibrillary tangles 
(NFTs). Amyloid plaques are composed of amyloid-β while NFTs are made up of 
hyperphosphorylated tau. Expression of ubiquitin aggregations is positive in both plaques 
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and tangles (Perry et al., 1987; Morishima-Kawashima et al., 1993). Several studies 
demonstrated direct evidence of altered proteasome activity in AD brains (Keck et al., 
2003; Keller et al., 2000). Alteration in proteasome subunit composition in AD has also 
been reported (Mishto et al., 2006). Furthermore, Uch-l1 is oxidized in AD and down-
regulated in the specific brain regions of early AD cases (Castegna et al., 2002; Pasinetti, 
2001).  
 
Indeed, inhibition of UPS is reflected in H2S-mediated neuronal apoptosis where 
substantial transcriptional down-regulation of genes encoding UPS-related proteins took 
place at the late 24 h phase (Table 3.3.7), coinciding with the occurrence of ER stress 
(Table 3.3.2). The UPS dysfunction is further substantiated by the protein down-regulation 
of Uchl1, Psmb2 and Ube2n in proteomics analysis (Table 3.4.3). These findings further 
supported H2S association with stroke (Qu et al., 2006), Down syndrome (Kamoun et al., 
2003) and possibly AD (Clarke et al., 1998; Morrison et al., 1996; Beyer et al., 2004). 
 
4.3 Similarities and differences between H2S- and NMDA-mediated neuronal deaths 
Establishment of similarities and difference between H2S- and NMDA-mediated neuronal 
deaths particular promising area of study as H2S signaling cascades have been intertwined 
with that of NMDA receptor activation in numerous physiological cellular events: (a) 
Physiological levels of H2S have been observed to selectively potentiate NMDA receptor-
mediated processes indirectly through events such as cAMP accumulation, thereby 
enhancing hippocampal LTP (Kimura et al., 2000a). (b) H2S production by CBS is 
increased by NMDA, AMPA and L-glutamate though it is tightly regulated by calcium-
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cadmodulin family (Eto et al., 2002). (c) H2S is capable of inducing calcium waves in 
primary cultures of rat astrocytes and hippocampal slices through calcium channels 
activation, a phenomenon also observed in NMDA receptors over-stimulation (Nagai et al., 
2004). 
 
Through the thorough study of microarray data of involvement of various cellular pathways 
at the various time-points, proposed signaling mechanisms for H2S- and NMDA-mediated 
neuronal deaths could be inferred. 
 
Table 4.3 Timeline of occurrence of various cellular signaling pathways at different phases of (A) H2S- and (B) 
NMDA-mediated neuronal deaths. 
(A) H2S-mediated neuronal death 
5 h 15 h 24 h 
Perturbed Calcium Homeostasis 
 Apoptosis ER Stress 
 Hsps and Chaperones UPS Dysfunction 




(B) NMDA-mediated neuronal death 
5 h 15 h 24 h 
Perturbed Calcium Homeostasis 
Apoptosis UPS Dysfunction 
ER Stress  
Hsps and Chaperones 
Inhibition of cell survival 
and proliferation  
 
 
As demonstrated in Table 4.3 A and B, a comparison between the occurrence of respective 
cellular events in H2S- and NMDA-mediated neuronal deaths revealed identical cellular 
pathways being involved in both models. These suggested an overlapping of signaling 
mechanisms in both death models, and provided further evidence of NMDA receptors 




the mediation of neuronal death was crucial in both models, demonstration of an 
excitotoxic death. 
 
However, an earlier occurrence of these events in NMDA-induced neuronal death was 
observed, as compared to a time-lag in that of H2S. This could be accounted for by the the 
direct induction of NMDA receptor activation through binding its specific pharmacological 
activator, NMDA. In contrast, though H2S mechanim of neuronal death induction has been 
associated with the NMDA receptor activation, it is not known yet how this interaction is 
brought about. It could be a direct stimulation of H2S on NMDA receptors with a lower 
binding affinity as compared to that of NMDA, or there is the presence of intermediary 
molecules to trigger the receptor activation. As such, both of these speculations could delay 
the late delay in activation of subsequent downstream signaling cascades. 
 
4.4 Comparison of UPS gene profiles among H2S, NO and lactacystin neuronal 
treatments 
A cross comparison of UPS-related gene profiles between H2S and NO-treatments against 
that of a classical proteasome inhibitor, lactacystin, is useful as it provides insights into the 
upstream and downstream cell death signaling mechanisms elicited by H2S and NO, since 
both of which function as neuromodulators and have been implicated in neurodegeneration 
with UPS dysfunction being reported. Moreover, H2S and NO have been reported to cross-
regulate each other’s activity: a) NO released from a NO donor increases H2S production 
speculated to be through CSE/CBS induction or activation (Hosoki et al., 1997); b) NO 
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regulates smooth muscle tone in synergy with H2S (Zhao et al., 2001); c) H2S inhibits 
activity of three isoforms of recombinant nitric oxide synthase (Kubo et al., 2007b). 
 
NO, ubiquitously expressed in the central nervous system and perceived to be a potential 
neuromodulator, has been implicated in the inhibition of UPS with consequential apoptotic 
neuronal death (Peng et al., 2008). Peng et al., 2008 demonstrated that UPS dysfunction is 
a consequential effect of NO-mediated apoptosis and not a triggering event. Exposure of 
cells to s-nitrosoglutathione and excess stimulation of endogenous NO production could 
result in inhibition of proteasome activity (Glockzin et al., 1999). Furthermore, s-
nitrosylation of proteins such as parkin (E3 ligase; Chung et al., 2004; Lipton et al., 2005; 
Yao et al., 2004) and Uchl1(Choi et al., 2004; Nishikawa et al., 2003) by NO, and 
subsequent oxidation resulted in enzymatic dysfunction and consequential UPS inhibition.  
 
Time-course analysis revealed similar down-regulatory observations with a low onset of 
reduction in proteasome function between NO and H2S-induced UPS suppression (Table 
3.3.7.1). Meiner et al., 2003 demonstrated that in the model of an exclusive proteasome 
dysfunction-induced cell death, a compensatory autoregulatory feedback mechanism 
resulting in the compensation of decrease proteasomal activity of will be triggered with an 
initial and concerted up-regulation of genes encoding proteins involved in UPS such as 26S 
proteasome subunit mRNAs. This in turn equated to an enhanced synthesis of all 
proteasomal subunits and as a whole increase the total number of functional proteasomes 
(Meiner et al., 2003). This was indeed the situation when neurons were treated with 
lactacystin, a classic proteasomal inhibitor. However, as a completely opposite UPS 
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regulatory profile was H2S-induced neuronal death, it iwas an indication that H2S-triggered 
neuronal death takes on a different signaling cascade from that of a classical proteasome 
inhibitor, and that decrease in UPS efficiency posed as a downstream consequential effect 




Elucidation of H2S-mediated neuronal apoptosis through global gene profiling has provided 
many insights regarding the sequential occurrence of cellular events upon cell death 
induction. As this is the first time H2S has been demonstrated to induce neuronal death, 
microarray data provided the evidence of H2S-mediated neuronal death converging into the 
NMDA receptor-activated signaling cascades, which explains the neuroprotective offered 
by specific NMDA receptor antagonist upon co-application with NaHS. Role of NMDA 
receptors in H2S-induced neuronal death could not be undermined. As such, it is important 
to re-evaluate the role of H2S in the physio-pathogenesis of various neurodegenerative 
disorders such as AD, Down syndrome and stroke with respective to NMDA receptors and 
not forgetting KA receptors where specific KA receptor antagonists also demonstrated 
neuroprotection in NAHS treatment. Prominent role of NMDA and KA receptors though 
currently lacking, but should not be neglected in future study of H2S effects in 
physiological and pathological conditions. 
 
Nevertheless, much future work is still required to focus on the unknown upstream 
signaling mechanism induced by H2S that lead to NMDA and KA receptors. Current study 
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only demonstrated that co-application of NaHS with NMDA ans KA receptor antagonists 
could avert neuronal death, only a partial clue to the whole jigsaw puzzle of H2S signaling 
cascade. Only by revealing how H2S interacted with these GluRs, could the usefulness of 
the specific pharmacological antagonists for these GluRs be appreciated and may aid as 
potential therapeutic revenues for treatment of neurodegenerative disorders. 
 
 
In addition, since the affinity of GluRs to individual agonists and antagonists is determined 
by the different combinations of their multimeric assemblies of subunits, with each 
assembly eliciting a different signaling cascade, lentiviral vectors which knock down 
different NMDA receptor subunits expression can be employed to determine if elimination 
of a subunit will impose an inhibitory or enhanced effect on H2S-mediated neuronal death. 
 
In addition, as KA receptors have also been implicated in H2S-mediated neuronal death, 
microarray experiment could be done similarly to determine any converging signaling 
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